PMIDs,Notes,Display_item,Participant,Age,Sex,Country/Region,Virus,Assay,Antibody,Antibody_unit,Antibody_value,Seropositivity,Cutoff,Time,Time_unit,Aggregated_data,Number_of_positive,Total_number,Severity
25162889,Not clear which antibodies the results refer to.,Table 3,Household contacts,,,Saudi Arabia,MERS-CoV,ELISA,IgG/IgM,Proportion,,,,0-2,week,TRUE,8,127,
25162889,Not clear which antibodies the results refer to.,Table 3,Household contacts,,,Saudi Arabia,MERS-CoV,ELISA,IgG/IgM,Proportion,,,,3-Feb,week,TRUE,3,45,
25162889,Not clear which antibodies the results refer to.,Table 3,Household contacts,,,Saudi Arabia,MERS-CoV,ELISA,IgG/IgM,Proportion,,,,>3,week,TRUE,11,108,
25162889,Not clear which antibodies the results refer to.,Table 3,Household contacts,,,Saudi Arabia,MERS-CoV,IFA,IgM,Proportion,,,,0-2,week,TRUE,1,127,
25162889,Not clear which antibodies the results refer to.,Table 3,Household contacts,,,Saudi Arabia,MERS-CoV,IFA,IgM,Proportion,,,,3-Feb,week,TRUE,3,45,
25162889,Not clear which antibodies the results refer to.,Table 3,Household contacts,,,Saudi Arabia,MERS-CoV,IFA,IgM,Proportion,,,,>3,week,TRUE,3,108,
25162889,Not clear which antibodies the results refer to.,Table 3,Household contacts,,,Saudi Arabia,MERS-CoV,IFA and PRNT,IgG/IgM/neutralizing,Proportion,,,,0-2,week,TRUE,1,127,
25162889,Not clear which antibodies the results refer to.,Table 3,Household contacts,,,Saudi Arabia,MERS-CoV,IFA and PRNT,IgG/IgM/neutralizing,Proportion,,,,3-Feb,week,TRUE,3,45,
25162889,Not clear which antibodies the results refer to.,Table 3,Household contacts,,,Saudi Arabia,MERS-CoV,IFA and PRNT,IgG/IgM/neutralizing,Proportion,,,,>3,week,TRUE,1,108,
25288266,,Figure 1,Case,,,Greece,MERS-CoV,IFA,IgM,Titre,100,,10,13,day,FALSE,,,
25288266,,Figure 1,Case,,,Greece,MERS-CoV,IFA,IgM,Titre,100,,10,15,day,FALSE,,,
25288266,,Figure 1,Case,,,Greece,MERS-CoV,IFA,IgM,Titre,100,,10,20,day,FALSE,,,
25288266,,Figure 1,Case,,,Greece,MERS-CoV,IFA,IgM,Titre,100,,10,24,day,FALSE,,,
25288266,,Figure 1,Case,,,Greece,MERS-CoV,IFA,IgM,Titre,100,,10,29,day,FALSE,,,
25288266,,Figure 1,Case,,,Greece,MERS-CoV,IFA,IgM,Titre,100,,10,34,day,FALSE,,,
25288266,,Figure 1,Case,,,Greece,MERS-CoV,IFA,IgG,Titre,100,,10,13,day,FALSE,,,
25288266,,Figure 1,Case,,,Greece,MERS-CoV,IFA,IgG,Titre,100,,10,15,day,FALSE,,,
25288266,,Figure 1,Case,,,Greece,MERS-CoV,IFA,IgG,Titre,3200,,100,20,day,FALSE,,,
25288266,,Figure 1,Case,,,Greece,MERS-CoV,IFA,IgG,Titre,10000,,100,24,day,FALSE,,,
25288266,,Figure 1,Case,,,Greece,MERS-CoV,IFA,IgG,Titre,3200,,100,29,day,FALSE,,,
25288266,,Figure 1,Case,,,Greece,MERS-CoV,IFA,IgG,Titre,3200,,100,34,day,FALSE,,,
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 1,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,80,,20,17,day,FALSE,,,Group 1: Received room air throughout hospitalization
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 1,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,80,,20,365,day,FALSE,,,Group 1: Received room air throughout hospitalization
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 2,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,10,,20,9,day,FALSE,,,Group 1: Received room air throughout hospitalization
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 2,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,10,,20,11,day,FALSE,,,Group 1: Received room air throughout hospitalization
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 2,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,320,,20,13,day,FALSE,,,Group 1: Received room air throughout hospitalization
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 2,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,160,,20,15,day,FALSE,,,Group 1: Received room air throughout hospitalization
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 2,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,80,,20,19,day,FALSE,,,Group 1: Received room air throughout hospitalization
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 2,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,80,,20,50,day,FALSE,,,Group 1: Received room air throughout hospitalization
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 2,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,40,,20,180,day,FALSE,,,Group 1: Received room air throughout hospitalization
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 2,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,20,,20,365,day,FALSE,,,Group 1: Received room air throughout hospitalization
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 3,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,,,20,9,day,FALSE,,,Group 1: Received room air throughout hospitalization
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 11,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,,,20,3,day,FALSE,,,Group 1: Received room air throughout hospitalization
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 19,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,,,20,1,day,FALSE,,,Group 1: Received room air throughout hospitalization
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 19,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,,,20,2,day,FALSE,,,Group 1: Received room air throughout hospitalization
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 22,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,,,20,6,day,FALSE,,,Group 1: Received room air throughout hospitalization
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 22,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,,,20,8,day,FALSE,,,Group 1: Received room air throughout hospitalization
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 23,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,,,20,13,day,FALSE,,,Group 1: Received room air throughout hospitalization
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 23,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,,,20,15,day,FALSE,,,Group 1: Received room air throughout hospitalization
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 24,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,160,,20,11,day,FALSE,,,Group 1: Received room air throughout hospitalization
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 41,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,40,,20,11,day,FALSE,,,Group 1: Received room air throughout hospitalization
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 26,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,,,20,15,day,FALSE,,,Group 1: Received room air throughout hospitalization
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 26,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,,,20,16,day,FALSE,,,Group 1: Received room air throughout hospitalization
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 39,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,,,20,5,day,FALSE,,,Group 1: Received room air throughout hospitalization
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 39,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,,,20,8,day,FALSE,,,Group 1: Received room air throughout hospitalization
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 30,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,,,20,5,day,FALSE,,,Group 2: required ventilator support and survived
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 13,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,,,20,6,day,FALSE,,,Group 2: required ventilator support and survived
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 13,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,,,20,12,day,FALSE,,,Group 2: required ventilator support and survived
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 27,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,80,,20,365,day,FALSE,,,Group 2: required ventilator support and survived
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 5,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,80,,20,26,day,FALSE,,,Group 2: required ventilator support and survived
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 5,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,40,,20,28,day,FALSE,,,Group 2: required ventilator support and survived
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 5,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,40,,20,30,day,FALSE,,,Group 2: required ventilator support and survived
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 5,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,80,,20,32,day,FALSE,,,Group 2: required ventilator support and survived
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 5,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,160,,20,34,day,FALSE,,,Group 2: required ventilator support and survived
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 5,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,160,,20,36,day,FALSE,,,Group 2: required ventilator support and survived
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 5,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,160,,20,39,day,FALSE,,,Group 2: required ventilator support and survived
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 5,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,80,,20,42,day,FALSE,,,Group 2: required ventilator support and survived
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 5,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,20,,20,67,day,FALSE,,,Group 2: required ventilator support and survived
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 9,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,,,20,15,day,FALSE,,,Group 2: required ventilator support and survived
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 9,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,160,,20,17,day,FALSE,,,Group 2: required ventilator support and survived
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 9,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,640,,20,21,day,FALSE,,,Group 2: required ventilator support and survived
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 9,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,320,,20,23,day,FALSE,,,Group 2: required ventilator support and survived
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 9,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,320,,20,25,day,FALSE,,,Group 2: required ventilator support and survived
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 9,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,320,,20,28,day,FALSE,,,Group 2: required ventilator support and survived
30882305,,Fig. 5 and Appendix 1 Figures 4–6,Case 9,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,40,,20,365,day,FALSE,,,Group 2: required ventilator support and survived
30882305,,Fig. 5 and Appendix 1 Figures 4–7,Case 21,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,640,,20,24,day,FALSE,,,Group 2: required ventilator support and survived
30882305,,Fig. 5 and Appendix 1 Figures 4–8,Case 21,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,640,,20,26,day,FALSE,,,Group 2: required ventilator support and survived
30882305,,Fig. 5 and Appendix 1 Figures 4–9,Case 21,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,640,,20,30,day,FALSE,,,Group 2: required ventilator support and survived
30882305,,Fig. 5 and Appendix 1 Figures 4–9,Case 4,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,640,,20,12,day,FALSE,,,Group 3: required ventilator support and died
30882305,,Fig. 5 and Appendix 1 Figures 4–9,Case 4,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,320,,20,14,day,FALSE,,,Group 3: required ventilator support and died
30882305,,Fig. 5 and Appendix 1 Figures 4–9,Case 4,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,320,,20,16,day,FALSE,,,Group 3: required ventilator support and died
30882305,,Fig. 5 and Appendix 1 Figures 4–9,Case 4,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,160,,20,18,day,FALSE,,,Group 3: required ventilator support and died
30882305,,Fig. 5 and Appendix 1 Figures 4–9,Case 4,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,640,,20,20,day,FALSE,,,Group 3: required ventilator support and died
30882305,,Fig. 5 and Appendix 1 Figures 4–9,Case 4,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,160,,20,22,day,FALSE,,,Group 3: required ventilator support and died
30882305,,Fig. 5 and Appendix 1 Figures 4–9,Case 4,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,160,,20,25,day,FALSE,,,Group 3: required ventilator support and died
30882305,,Fig. 5 and Appendix 1 Figures 4–9,Case 4,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,160,,20,28,day,FALSE,,,Group 3: required ventilator support and died
30882305,,Fig. 5 and Appendix 1 Figures 4–9,Case 6,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,40,,20,8,day,FALSE,,,Group 3: required ventilator support and died
30882305,,Fig. 5 and Appendix 1 Figures 4–9,Case 6,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,80,,20,10,day,FALSE,,,Group 3: required ventilator support and died
30882305,,Fig. 5 and Appendix 1 Figures 4–9,Case 7,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,80,,20,6,day,FALSE,,,Group 3: required ventilator support and died
30882305,,Fig. 5 and Appendix 1 Figures 4–9,Case 7,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,160,,20,7,day,FALSE,,,Group 3: required ventilator support and died
30882305,,Fig. 5 and Appendix 1 Figures 4–9,Case 7,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,160,,20,9,day,FALSE,,,Group 3: required ventilator support and died
30882305,,Fig. 5 and Appendix 1 Figures 4–9,Case 8,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,,,20,11,day,FALSE,,,Group 3: required ventilator support and died
30882305,,Fig. 5 and Appendix 1 Figures 4–9,Case 8,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,,,20,13,day,FALSE,,,Group 3: required ventilator support and died
30882305,,Fig. 5 and Appendix 1 Figures 4–9,Case 8,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,80,,20,15,day,FALSE,,,Group 3: required ventilator support and died
30882305,,Fig. 5 and Appendix 1 Figures 4–9,Case 8,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,20,,20,17,day,FALSE,,,Group 3: required ventilator support and died
30882305,,Fig. 5 and Appendix 1 Figures 4–9,Case 8,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,80,,20,21,day,FALSE,,,Group 3: required ventilator support and died
30882305,,Fig. 5 and Appendix 1 Figures 4–9,Case 8,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,40,,20,24,day,FALSE,,,Group 3: required ventilator support and died
30882305,,Fig. 5 and Appendix 1 Figures 4–9,Case 8,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,40,,20,27,day,FALSE,,,Group 3: required ventilator support and died
30882305,,Fig. 5 and Appendix 1 Figures 4–9,Case 10,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,160,,20,21,day,FALSE,,,Group 3: required ventilator support and died
30882305,,Fig. 5 and Appendix 1 Figures 4–9,Case 10,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,40,,20,23,day,FALSE,,,Group 3: required ventilator support and died
30882305,,Fig. 5 and Appendix 1 Figures 4–9,Case 10,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,80,,20,25,day,FALSE,,,Group 3: required ventilator support and died
30882305,,Fig. 5 and Appendix 1 Figures 4–9,Case 12,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,20,,20,8,day,FALSE,,,Group 3: required ventilator support and died
30882305,,Fig. 5 and Appendix 1 Figures 4–9,Case 12,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,160,,20,10,day,FALSE,,,Group 3: required ventilator support and died
30882305,,Fig. 5 and Appendix 1 Figures 4–9,Case 14,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,80,,20,15,day,FALSE,,,Group 3: required ventilator support and died
30882305,,Fig. 5 and Appendix 1 Figures 4–9,Case 14,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,640,,20,19,day,FALSE,,,Group 3: required ventilator support and died
30882305,,Fig. 5 and Appendix 1 Figures 4–9,Case 14,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,640,,20,23,day,FALSE,,,Group 3: required ventilator support and died
30882305,,Fig. 5 and Appendix 1 Figures 4–9,Case 15,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,20,,20,6,day,FALSE,,,Group 3: required ventilator support and died
30882305,,Fig. 5 and Appendix 1 Figures 4–9,Case 20,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,640,,20,31,day,FALSE,,,Group 3: required ventilator support and died
30882305,,Fig. 5 and Appendix 1 Figures 4–9,Case 20,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,640,,20,37,day,FALSE,,,Group 3: required ventilator support and died
30882305,,Fig. 5 and Appendix 1 Figures 4–9,Case 28,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,160,,20,45,day,FALSE,,,Group 3: required ventilator support and died
30882305,,Fig. 5 and Appendix 1 Figures 4–9,Case 31,,,Saudi Arabia,MERS-CoV,MN,Neutralizing,Titre,80,,20,14,day,FALSE,,,Group 3: required ventilator support and died
31423971,,Table 2,Case 1,23,,Saudi Arabia,MERS-CoV,S1 ELISA,IgG,OD?,1.586,,,33,day,FALSE,,,
31423971,,Table 2,Case 1,23,,Saudi Arabia,MERS-CoV,S1 ELISA,IgG,OD?,0.523,,,163,day,FALSE,,,
31423971,,Table 2,Case 5,28,,Saudi Arabia,MERS-CoV,S1 ELISA,IgG,OD?,3.154,,,43,day,FALSE,,,
31423971,,Table 2,Case 5,28,,Saudi Arabia,MERS-CoV,S1 ELISA,IgG,OD?,2.741,,,173,day,FALSE,,,
31423971,,Table 2,Case 10,37,,Saudi Arabia,MERS-CoV,S1 ELISA,IgG,OD?,1.214,,,34,day,FALSE,,,
31423971,,Table 2,Case 10,37,,Saudi Arabia,MERS-CoV,S1 ELISA,IgG,OD?,0.569,,,164,day,FALSE,,,
31423971,,Table 2,Case 11,30,,Saudi Arabia,MERS-CoV,S1 ELISA,IgG,OD?,0.759,,,22,day,FALSE,,,
31423971,,Table 2,Case 11,30,,Saudi Arabia,MERS-CoV,S1 ELISA,IgG,OD?,0.605,,,152,day,FALSE,,,
31423971,,Table 2,Case 13,32,,Saudi Arabia,MERS-CoV,S1 ELISA,IgG,OD?,3.381,,,48,day,FALSE,,,
31423971,,Table 2,Case 13,32,,Saudi Arabia,MERS-CoV,S1 ELISA,IgG,OD?,1.012,,,178,day,FALSE,,,
31423971,,Table 2,Case 14,28,,Saudi Arabia,MERS-CoV,S1 ELISA,IgG,OD?,1.999,,,55,day,FALSE,,,
31423971,,Table 2,Case 14,28,,Saudi Arabia,MERS-CoV,S1 ELISA,IgG,OD?,1.654,,,185,day,FALSE,,,
31423971,,Table 2,Case 1,23,,Saudi Arabia,MERS-CoV,ppNT,Neutralizing,Titre,80,,20,33,day,FALSE,,,
31423971,,Table 2,Case 1,23,,Saudi Arabia,MERS-CoV,ppNT,Neutralizing,Titre,20,,20,163,day,FALSE,,,
31423971,,Table 2,Case 5,28,,Saudi Arabia,MERS-CoV,ppNT,Neutralizing,Titre,160,,20,43,day,FALSE,,,
31423971,,Table 2,Case 5,28,,Saudi Arabia,MERS-CoV,ppNT,Neutralizing,Titre,160,,20,173,day,FALSE,,,
31423971,,Table 2,Case 10,37,,Saudi Arabia,MERS-CoV,ppNT,Neutralizing,Titre,40,,20,34,day,FALSE,,,
31423971,,Table 2,Case 10,37,,Saudi Arabia,MERS-CoV,ppNT,Neutralizing,Titre,20,,20,164,day,FALSE,,,
31423971,,Table 2,Case 11,30,,Saudi Arabia,MERS-CoV,ppNT,Neutralizing,Titre,20,,20,22,day,FALSE,,,
31423971,,Table 2,Case 11,30,,Saudi Arabia,MERS-CoV,ppNT,Neutralizing,Titre,20,,20,152,day,FALSE,,,
31423971,,Table 2,Case 13,32,,Saudi Arabia,MERS-CoV,ppNT,Neutralizing,Titre,80,,20,48,day,FALSE,,,
31423971,,Table 2,Case 13,32,,Saudi Arabia,MERS-CoV,ppNT,Neutralizing,Titre,20,,20,178,day,FALSE,,,
31423971,,Table 2,Case 14,28,,Saudi Arabia,MERS-CoV,ppNT,Neutralizing,Titre,40,,20,55,day,FALSE,,,
31423971,,Table 2,Case 14,28,,Saudi Arabia,MERS-CoV,ppNT,Neutralizing,Titre,40,,20,185,day,FALSE,,,
31423971,,Table 2,Case 1,23,,Saudi Arabia,MERS-CoV,PRNT (90),Neutralizing,Titre,20,,20,33,day,FALSE,,,
31423971,,Table 2,Case 1,23,,Saudi Arabia,MERS-CoV,PRNT (90),Neutralizing,Titre,10,,20,163,day,FALSE,,,
31423971,,Table 2,Case 5,28,,Saudi Arabia,MERS-CoV,PRNT (90),Neutralizing,Titre,40,,20,43,day,FALSE,,,
31423971,,Table 2,Case 5,28,,Saudi Arabia,MERS-CoV,PRNT (90),Neutralizing,Titre,40,,20,173,day,FALSE,,,
31423971,,Table 2,Case 10,37,,Saudi Arabia,MERS-CoV,PRNT (90),Neutralizing,Titre,10,,20,34,day,FALSE,,,
31423971,,Table 2,Case 10,37,,Saudi Arabia,MERS-CoV,PRNT (90),Neutralizing,Titre,5,,20,164,day,FALSE,,,
31423971,,Table 2,Case 11,30,,Saudi Arabia,MERS-CoV,PRNT (90),Neutralizing,Titre,10,,20,22,day,FALSE,,,
31423971,,Table 2,Case 11,30,,Saudi Arabia,MERS-CoV,PRNT (90),Neutralizing,Titre,5,,20,152,day,FALSE,,,
31423971,,Table 2,Case 13,32,,Saudi Arabia,MERS-CoV,PRNT (90),Neutralizing,Titre,20,,20,48,day,FALSE,,,
31423971,,Table 2,Case 13,32,,Saudi Arabia,MERS-CoV,PRNT (90),Neutralizing,Titre,10,,20,178,day,FALSE,,,
31423971,,Table 2,Case 14,28,,Saudi Arabia,MERS-CoV,PRNT (90),Neutralizing,Titre,10,,20,55,day,FALSE,,,
31423971,,Table 2,Case 14,28,,Saudi Arabia,MERS-CoV,PRNT (90),Neutralizing,Titre,20,,20,185,day,FALSE,,,
31423970,,Figure 1,Case 1,,,,MERS-CoV,S1 iELISA,IgG,OD (450 nm),3.441176471,,0.6,6,month,FALSE,,,Severe
31423970,,Figure 1,Case 1,,,,MERS-CoV,S1 iELISA,IgG,OD (450 nm),3.029411765,,1,9,month,FALSE,,,Severe
31423970,,Figure 1,Case 1,,,,MERS-CoV,S1 iELISA,IgG,OD (450 nm),3.308823529,,1,12,month,FALSE,,,Severe
31423970,,Figure 1,Case 2,,,,MERS-CoV,S1 iELISA,IgG,OD (450 nm),3.308823529,,1,6,month,FALSE,,,Severe
31423970,,Figure 1,Case 2,,,,MERS-CoV,S1 iELISA,IgG,OD (450 nm),3.191176471,,1,9,month,FALSE,,,Severe
31423970,,Figure 1,Case 2,,,,MERS-CoV,S1 iELISA,IgG,OD (450 nm),3.132352941,,1,12,month,FALSE,,,Severe
31423970,,Figure 1,Case 3,,,,MERS-CoV,S1 iELISA,IgG,OD (450 nm),3.235294118,,1,6,month,FALSE,,,Severe
31423970,,Figure 1,Case 3,,,,MERS-CoV,S1 iELISA,IgG,OD (450 nm),3.102941176,,1,9,month,FALSE,,,Severe
31423970,,Figure 1,Case 3,,,,MERS-CoV,S1 iELISA,IgG,OD (450 nm),3,,1,12,month,FALSE,,,Severe
31423970,,Figure 1,Case 4,,,,MERS-CoV,S1 iELISA,IgG,OD (450 nm),3.102941176,,1,6,month,FALSE,,,Severe
31423970,,Figure 1,Case 4,,,,MERS-CoV,S1 iELISA,IgG,OD (450 nm),2.823529412,,1,9,month,FALSE,,,Severe
31423970,,Figure 1,Case 4,,,,MERS-CoV,S1 iELISA,IgG,OD (450 nm),2.779411765,,1,12,month,FALSE,,,Severe
31423970,,Figure 1,Case 5,,,,MERS-CoV,S1 iELISA,IgG,OD (450 nm),2.941176471,,1,6,month,FALSE,,,Severe
31423970,,Figure 1,Case 5,,,,MERS-CoV,S1 iELISA,IgG,OD (450 nm),2.852941176,,1,9,month,FALSE,,,Severe
31423970,,Figure 1,Case 5,,,,MERS-CoV,S1 iELISA,IgG,OD (450 nm),2.632352941,,1,12,month,FALSE,,,Severe
31423970,,Figure 1,Case 6,,,,MERS-CoV,S1 iELISA,IgG,OD (450 nm),2.941176471,,1,6,month,FALSE,,,Mild
31423970,,Figure 1,Case 6,,,,MERS-CoV,S1 iELISA,IgG,OD (450 nm),2.794117647,,1,9,month,FALSE,,,Mild
31423970,,Figure 1,Case 6,,,,MERS-CoV,S1 iELISA,IgG,OD (450 nm),2.661764706,,1,12,month,FALSE,,,Mild
31423970,,Figure 1,Case 7,,,,MERS-CoV,S1 iELISA,IgG,OD (450 nm),2.75,,1,6,month,FALSE,,,Mild
31423970,,Figure 1,Case 7,,,,MERS-CoV,S1 iELISA,IgG,OD (450 nm),2.838235294,,1,9,month,FALSE,,,Mild
31423970,,Figure 1,Case 7,,,,MERS-CoV,S1 iELISA,IgG,OD (450 nm),2.75,,1,12,month,FALSE,,,Mild
31423970,,Figure 1,Case 8,,,,MERS-CoV,S1 iELISA,IgG,OD (450 nm),2.176470588,,1,6,month,FALSE,,,Mild
31423970,,Figure 1,Case 8,,,,MERS-CoV,S1 iELISA,IgG,OD (450 nm),1.75,,1,9,month,FALSE,,,Mild
31423970,,Figure 1,Case 8,,,,MERS-CoV,S1 iELISA,IgG,OD (450 nm),1.573529412,,1,12,month,FALSE,,,Mild
31423970,,Figure 1,Case 9,,,,MERS-CoV,S1 iELISA,IgG,OD (450 nm),2.117647059,,1,6,month,FALSE,,,Mild
31423970,,Figure 1,Case 9,,,,MERS-CoV,S1 iELISA,IgG,OD (450 nm),1.75,,1,9,month,FALSE,,,Mild
31423970,,Figure 1,Case 9,,,,MERS-CoV,S1 iELISA,IgG,OD (450 nm),1.897058824,,1,12,month,FALSE,,,Mild
31423970,,Figure 1,Case 10,,,,MERS-CoV,S1 iELISA,IgG,OD (450 nm),0.794117647,,1,6,month,FALSE,,,Mild
31423970,,Figure 1,Case 10,,,,MERS-CoV,S1 iELISA,IgG,OD (450 nm),0.705882353,,1,9,month,FALSE,,,Mild
31423970,,Figure 1,Case 10,,,,MERS-CoV,S1 iELISA,IgG,OD (450 nm),0.779411765,,1,12,month,FALSE,,,Mild
31423970,,Figure 1,Case 11,,,,MERS-CoV,S1 iELISA,IgG,OD (450 nm),0.367647059,,1,6,month,FALSE,,,Mild
31423970,,Figure 1,Case 11,,,,MERS-CoV,S1 iELISA,IgG,OD (450 nm),0.397058824,,1,9,month,FALSE,,,Mild
31423970,,Figure 1,Case 11,,,,MERS-CoV,S1 iELISA,IgG,OD (450 nm),0.426470588,,1,12,month,FALSE,,,Mild
32065057,,Figure 1,Case 1,,,,SARS-CoV-2,ELISA,IgM,Seropositive,,positive,0.15,0,day,FALSE,,,
32065057,,Figure 1,Case 1,,,,SARS-CoV-2,ELISA,IgM,Seropositive,,positive,0.15,5,day,FALSE,,,
32065057,,Figure 1,Case 1,,,,SARS-CoV-2,ELISA,IgG,Seropositive,,positive,0.15,0,day,FALSE,,,
32065057,,Figure 1,Case 1,,,,SARS-CoV-2,ELISA,IgG,Seropositive,,positive,0.15,5,day,FALSE,,,
32065057,,Figure 1,Case 2,,,,SARS-CoV-2,ELISA,IgM,Seropositive,,negative,0.15,0,day,FALSE,,,
32065057,,Figure 1,Case 2,,,,SARS-CoV-2,ELISA,IgM,Seropositive,,positive,0.15,5,day,FALSE,,,
32065057,,Figure 1,Case 2,,,,SARS-CoV-2,ELISA,IgG,Seropositive,,negative,0.15,0,day,FALSE,,,
32065057,,Figure 1,Case 2,,,,SARS-CoV-2,ELISA,IgG,Seropositive,,positive,0.15,5,day,FALSE,,,
32065057,,Figure 1,Case 3,,,,SARS-CoV-2,ELISA,IgM,Seropositive,,positive,0.15,0,day,FALSE,,,
32065057,,Figure 1,Case 3,,,,SARS-CoV-2,ELISA,IgM,Seropositive,,positive,0.15,5,day,FALSE,,,
32065057,,Figure 1,Case 3,,,,SARS-CoV-2,ELISA,IgG,Seropositive,,positive,0.15,0,day,FALSE,,,
32065057,,Figure 1,Case 3,,,,SARS-CoV-2,ELISA,IgG,Seropositive,,positive,0.15,5,day,FALSE,,,
32065057,,Figure 1,Case 4,,,,SARS-CoV-2,ELISA,IgM,Seropositive,,negative,0.15,0,day,FALSE,,,
32065057,,Figure 1,Case 4,,,,SARS-CoV-2,ELISA,IgM,Seropositive,,positive,0.15,5,day,FALSE,,,
32065057,,Figure 1,Case 4,,,,SARS-CoV-2,ELISA,IgG,Seropositive,,positive,0.15,0,day,FALSE,,,
32065057,,Figure 1,Case 4,,,,SARS-CoV-2,ELISA,IgG,Seropositive,,positive,0.15,5,day,FALSE,,,
32065057,,Figure 1,Case 5,,,,SARS-CoV-2,ELISA,IgM,Seropositive,,negative,0.15,0,day,FALSE,,,
32065057,,Figure 1,Case 5,,,,SARS-CoV-2,ELISA,IgM,Seropositive,,negative,0.15,5,day,FALSE,,,
32065057,,Figure 1,Case 5,,,,SARS-CoV-2,ELISA,IgG,Seropositive,,positive,0.15,0,day,FALSE,,,
32065057,,Figure 1,Case 5,,,,SARS-CoV-2,ELISA,IgG,Seropositive,,positive,0.15,5,day,FALSE,,,
32065057,,Figure 1,Case 6,,,,SARS-CoV-2,ELISA,IgM,Seropositive,,positive,0.15,0,day,FALSE,,,
32065057,,Figure 1,Case 6,,,,SARS-CoV-2,ELISA,IgM,Seropositive,,positive,0.15,5,day,FALSE,,,
32065057,,Figure 1,Case 6,,,,SARS-CoV-2,ELISA,IgG,Seropositive,,positive,0.15,0,day,FALSE,,,
32065057,,Figure 1,Case 6,,,,SARS-CoV-2,ELISA,IgG,Seropositive,,positive,0.15,5,day,FALSE,,,
32065057,,Figure 1,Case 7,,,,SARS-CoV-2,ELISA,IgM,Seropositive,,negative,0.15,0,day,FALSE,,,
32065057,,Figure 1,Case 7,,,,SARS-CoV-2,ELISA,IgM,Seropositive,,positive,0.15,5,day,FALSE,,,
32065057,,Figure 1,Case 7,,,,SARS-CoV-2,ELISA,IgG,Seropositive,,negative,0.15,0,day,FALSE,,,
32065057,,Figure 1,Case 7,,,,SARS-CoV-2,ELISA,IgG,Seropositive,,positive,0.15,5,day,FALSE,,,
32065057,,Figure 1,Case 8,,,,SARS-CoV-2,ELISA,IgM,Seropositive,,positive,0.15,0,day,FALSE,,,
32065057,,Figure 1,Case 8,,,,SARS-CoV-2,ELISA,IgM,Seropositive,,positive,0.15,5,day,FALSE,,,
32065057,,Figure 1,Case 8,,,,SARS-CoV-2,ELISA,IgG,Seropositive,,positive,0.15,0,day,FALSE,,,
32065057,,Figure 1,Case 8,,,,SARS-CoV-2,ELISA,IgG,Seropositive,,positive,0.15,5,day,FALSE,,,
32065057,,Figure 1,Case 9,,,,SARS-CoV-2,ELISA,IgM,Seropositive,,negative,0.15,0,day,FALSE,,,
32065057,,Figure 1,Case 9,,,,SARS-CoV-2,ELISA,IgM,Seropositive,,positive,0.15,5,day,FALSE,,,
32065057,,Figure 1,Case 9,,,,SARS-CoV-2,ELISA,IgG,Seropositive,,positive,0.15,0,day,FALSE,,,
32065057,,Figure 1,Case 9,,,,SARS-CoV-2,ELISA,IgG,Seropositive,,positive,0.15,5,day,FALSE,,,
32065057,,Figure 1,Case 10,,,,SARS-CoV-2,ELISA,IgM,Seropositive,,positive,0.15,0,day,FALSE,,,
32065057,,Figure 1,Case 10,,,,SARS-CoV-2,ELISA,IgM,Seropositive,,negative,0.15,5,day,FALSE,,,
32065057,,Figure 1,Case 10,,,,SARS-CoV-2,ELISA,IgG,Seropositive,,positive,0.15,0,day,FALSE,,,
32065057,,Figure 1,Case 10,,,,SARS-CoV-2,ELISA,IgG,Seropositive,,positive,0.15,5,day,FALSE,,,
32065057,,Figure 1,Case 11,,,,SARS-CoV-2,ELISA,IgM,Seropositive,,positive,0.15,0,day,FALSE,,,
32065057,,Figure 1,Case 11,,,,SARS-CoV-2,ELISA,IgM,Seropositive,,positive,0.15,5,day,FALSE,,,
32065057,,Figure 1,Case 11,,,,SARS-CoV-2,ELISA,IgG,Seropositive,,positive,0.15,0,day,FALSE,,,
32065057,,Figure 1,Case 11,,,,SARS-CoV-2,ELISA,IgG,Seropositive,,positive,0.15,5,day,FALSE,,,
32065057,,Figure 1,Case 12,,,,SARS-CoV-2,ELISA,IgM,Seropositive,,negative,0.15,0,day,FALSE,,,
32065057,,Figure 1,Case 12,,,,SARS-CoV-2,ELISA,IgM,Seropositive,,negative,0.15,5,day,FALSE,,,
32065057,,Figure 1,Case 12,,,,SARS-CoV-2,ELISA,IgG,Seropositive,,positive,0.15,0,day,FALSE,,,
32065057,,Figure 1,Case 12,,,,SARS-CoV-2,ELISA,IgG,Seropositive,,positive,0.15,5,day,FALSE,,,
32065057,,Figure 1,Case 13,,,,SARS-CoV-2,ELISA,IgM,Seropositive,,positive,0.15,0,day,FALSE,,,
32065057,,Figure 1,Case 13,,,,SARS-CoV-2,ELISA,IgM,Seropositive,,positive,0.15,5,day,FALSE,,,
32065057,,Figure 1,Case 13,,,,SARS-CoV-2,ELISA,IgG,Seropositive,,positive,0.15,0,day,FALSE,,,
32065057,,Figure 1,Case 13,,,,SARS-CoV-2,ELISA,IgG,Seropositive,,positive,0.15,5,day,FALSE,,,
32065057,,Figure 1,Case 14,,,,SARS-CoV-2,ELISA,IgM,Seropositive,,negative,0.15,0,day,FALSE,,,
32065057,,Figure 1,Case 14,,,,SARS-CoV-2,ELISA,IgM,Seropositive,,positive,0.15,5,day,FALSE,,,
32065057,,Figure 1,Case 14,,,,SARS-CoV-2,ELISA,IgG,Seropositive,,positive,0.15,0,day,FALSE,,,
32065057,,Figure 1,Case 14,,,,SARS-CoV-2,ELISA,IgG,Seropositive,,positive,0.15,5,day,FALSE,,,
32065057,,Figure 1,Case 15,,,,SARS-CoV-2,ELISA,IgM,Seropositive,,positive,0.15,0,day,FALSE,,,
32065057,,Figure 1,Case 15,,,,SARS-CoV-2,ELISA,IgM,Seropositive,,positive,0.15,5,day,FALSE,,,
32065057,,Figure 1,Case 15,,,,SARS-CoV-2,ELISA,IgG,Seropositive,,positive,0.15,0,day,FALSE,,,
32065057,,Figure 1,Case 15,,,,SARS-CoV-2,ELISA,IgG,Seropositive,,positive,0.15,5,day,FALSE,,,
32065057,,Figure 1,Case 16,,,,SARS-CoV-2,ELISA,IgM,Seropositive,,negative,0.15,0,day,FALSE,,,
32065057,,Figure 1,Case 16,,,,SARS-CoV-2,ELISA,IgM,Seropositive,,positive,0.15,5,day,FALSE,,,
32065057,,Figure 1,Case 16,,,,SARS-CoV-2,ELISA,IgG,Seropositive,,negative,0.15,0,day,FALSE,,,
32065057,,Figure 1,Case 16,,,,SARS-CoV-2,ELISA,IgG,Seropositive,,positive,0.15,5,day,FALSE,,,
32073157,,Figure 1,Elderly,,,,HCoV-229E,ELISA,IgG,,1544,,,Acute,Categorical,TRUE,,,
32073157,,Figure 1,Elderly,,,,HCoV-NL63,ELISA,IgG,,276,,,Acute,Categorical,TRUE,,,
32073157,,Figure 1,Elderly,,,,HCoV-OC43,ELISA,IgG,,1804,,,Acute,Categorical,TRUE,,,
32073157,,Figure 1,Elderly,,,,HCoV-HKU1,ELISA,IgG,,355,,,Acute,Categorical,TRUE,,,
32073157,,Figure 1,Elderly,,,,HCoV-229E,ELISA,IgG,,1923,,,Convalescent,Categorical,TRUE,,,
32073157,,Figure 1,Elderly,,,,HCoV-NL63,ELISA,IgG,,555,,,Convalescent,Categorical,TRUE,,,
32073157,,Figure 1,Elderly,,,,HCoV-OC43,ELISA,IgG,,3771,,,Convalescent,Categorical,TRUE,,,
32073157,,Figure 1,Elderly,,,,HCoV-HKU1,ELISA,IgG,,814,,,Convalescent,Categorical,TRUE,,,
32073157,,Figure 1,Young adults,,,,HCoV-229E,ELISA,IgG,,487,,,Acute,Categorical,TRUE,,,
32073157,,Figure 1,Young adults,,,,HCoV-NL63,ELISA,IgG,,184,,,Acute,Categorical,TRUE,,,
32073157,,Figure 1,Young adults,,,,HCoV-OC43,ELISA,IgG,,1169,,,Acute,Categorical,TRUE,,,
32073157,,Figure 1,Young adults,,,,HCoV-HKU1,ELISA,IgG,,102,,,Acute,Categorical,TRUE,,,
32073157,,Figure 1,Young adults,,,,HCoV-229E,ELISA,IgG,,886,,,Convalescent,Categorical,TRUE,,,
32073157,,Figure 1,Young adults,,,,HCoV-NL63,ELISA,IgG,,624,,,Convalescent,Categorical,TRUE,,,
32073157,,Figure 1,Young adults,,,,HCoV-OC43,ELISA,IgG,,2453,,,Convalescent,Categorical,TRUE,,,
32073157,,Figure 1,Young adults,,,,HCoV-HKU1,ELISA,IgG,,401,,,Convalescent,Categorical,TRUE,,,
32073157,,Figure 1,Elderly,,,,HCoV-229E,NT,Neutralizing,,131,,,Acute,Categorical,TRUE,,,
32073157,,Figure 1,Elderly,,,,HCoV-NL63,NT,Neutralizing,,91,,,Acute,Categorical,TRUE,,,
32073157,,Figure 1,Elderly,,,,HCoV-OC43,NT,Neutralizing,,261,,,Acute,Categorical,TRUE,,,
32073157,,Figure 1,Elderly,,,,HCoV-229E,NT,Neutralizing,,190,,,Convalescent,Categorical,TRUE,,,
32073157,,Figure 1,Elderly,,,,HCoV-NL63,NT,Neutralizing,,96,,,Convalescent,Categorical,TRUE,,,
32073157,,Figure 1,Elderly,,,,HCoV-OC43,NT,Neutralizing,,329,,,Convalescent,Categorical,TRUE,,,
32073157,,Figure 1,Young adults,,,,HCoV-229E,NT,Neutralizing,,40,,,Acute,Categorical,TRUE,,,
32073157,,Figure 1,Young adults,,,,HCoV-NL63,NT,Neutralizing,,127,,,Acute,Categorical,TRUE,,,
32073157,,Figure 1,Young adults,,,,HCoV-OC43,NT,Neutralizing,,159,,,Acute,Categorical,TRUE,,,
32073157,,Figure 1,Young adults,,,,HCoV-229E,NT,Neutralizing,,43,,,Convalescent,Categorical,TRUE,,,
32073157,,Figure 1,Young adults,,,,HCoV-NL63,NT,Neutralizing,,139,,,Convalescent,Categorical,TRUE,,,
32073157,,Figure 1,Young adults,,,,HCoV-OC43,NT,Neutralizing,,202,,,Convalescent,Categorical,TRUE,,,
14519257,,Figure 2,Case 1,,,,SARS-CoV-1,IFA,IgG,Titre,100,,25,14,day,FALSE,,,
14519257,,Figure 2,Case 1,,,,SARS-CoV-1,IFA,IgG,Titre,800,,25,19,day,FALSE,,,
14519257,,Figure 2,Case 1,,,,SARS-CoV-1,IFA,IgG,Titre,>=1600,,25,21,day,FALSE,,,
14519257,,Figure 2,Case 1,,,,SARS-CoV-1,IFA,IgG,Titre,>=1600,,25,25,day,FALSE,,,
14519257,,Figure 2,Case 1,,,,SARS-CoV-1,IFA,IgG,Titre,>=1600,,25,27,day,FALSE,,,
14519257,,Figure 2,Case 1,,,,SARS-CoV-1,IFA,IgG,Titre,>=1600,,25,30,day,FALSE,,,
14519257,,Figure 2,Case 1,,,,SARS-CoV-1,IFA,IgG,Titre,>=1600,,25,36,day,FALSE,,,
14519257,,Figure 2,Case 1,,,,SARS-CoV-1,IFA,IgG,Titre,>=1600,,25,54,day,FALSE,,,
14519257,,Figure 2,Case 1,,,,SARS-CoV-1,IFA,IgG,Titre,>=1600,,25,70,day,FALSE,,,
14519257,,Figure 2,Case 2,,,,SARS-CoV-1,IFA,IgG,Titre,<25,,25,8,day,FALSE,,,
14519257,,Figure 2,Case 2,,,,SARS-CoV-1,IFA,IgG,Titre,400,,25,19,day,FALSE,,,
14519257,,Figure 2,Case 2,,,,SARS-CoV-1,IFA,IgG,Titre,400,,25,24,day,FALSE,,,
14519257,,Figure 2,Case 2,,,,SARS-CoV-1,IFA,IgG,Titre,400,,25,27,day,FALSE,,,
14519257,,Figure 2,Case 2,,,,SARS-CoV-1,IFA,IgG,Titre,400,,25,31,day,FALSE,,,
14519257,,Figure 2,Case 2,,,,SARS-CoV-1,IFA,IgG,Titre,400,,25,36,day,FALSE,,,
14519257,,Figure 2,Case 3,,,,SARS-CoV-1,IFA,IgG,Titre,100,,25,10,day,FALSE,,,
14519257,,Figure 2,Case 3,,,,SARS-CoV-1,IFA,IgG,Titre,400,,25,12,day,FALSE,,,
14519257,,Figure 2,Case 3,,,,SARS-CoV-1,IFA,IgG,Titre,800,,25,15,day,FALSE,,,
14519257,,Figure 2,Case 3,,,,SARS-CoV-1,IFA,IgG,Titre,>1600,,25,18,day,FALSE,,,
14519257,,Figure 2,Case 3,,,,SARS-CoV-1,IFA,IgG,Titre,>1600,,25,24,day,FALSE,,,
14519257,,Figure 2,Case 3,,,,SARS-CoV-1,IFA,IgG,Titre,>1600,,25,40,day,FALSE,,,
15030702,,Figure 2,,,,Taiwan,SARS-CoV-1,"NT, IFA, or ELISA",,Proportion,,,,D1-D7,day,TRUE,14,138,
15030702,,Figure 2,,,,Taiwan,SARS-CoV-1,"NT, IFA, or ELISA",,Proportion,,,,D8-D8,day,TRUE,6,39,
15030702,,Figure 2,,,,Taiwan,SARS-CoV-1,"NT, IFA, or ELISA",,Proportion,,,,D16-D21,day,TRUE,21,38,
15030702,,Figure 2,,,,Taiwan,SARS-CoV-1,"NT, IFA, or ELISA",,Proportion,,,,D22-D28,day,TRUE,22,49,
15030702,,Figure 2,,,,Taiwan,SARS-CoV-1,"NT, IFA, or ELISA",,Proportion,,,,D29-D35,day,TRUE,14,30,
15030702,,Figure 2,,,,Taiwan,SARS-CoV-1,"NT, IFA, or ELISA",,Proportion,,,,D36-D42,day,TRUE,20,41,
15030702,,Figure 2,,,,Taiwan,SARS-CoV-1,"NT, IFA, or ELISA",,Proportion,,,,D43-D49,day,TRUE,18,38,
15030702,,Figure 2,,,,Taiwan,SARS-CoV-1,"NT, IFA, or ELISA",,Proportion,,,,D50-D56,day,TRUE,29,49,
15030702,,Figure 2,,,,Taiwan,SARS-CoV-1,"NT, IFA, or ELISA",,Proportion,,,,D57-D63,day,TRUE,17,37,
15030702,,Figure 2,,,,Taiwan,SARS-CoV-1,"NT, IFA, or ELISA",,Proportion,,,,D64-D70,day,TRUE,19,33,
15030702,,Figure 2,,,,Taiwan,SARS-CoV-1,"NT, IFA, or ELISA",,Proportion,,,,>D70,day,TRUE,47,67,
4626012,antibody titer to 229E,Table 2,Case 237,,,US,HCov-229E,NT,Neutralizing,Titre,<4,,4,Pre,Categorical,FALSE,,,
4626012,antibody titer to 229E,Table 2,Case 237,,,US,HCov-229E,NT,Neutralizing,Titre,128,,4,Peak,Categorical,FALSE,,,
4626012,antibody titer to 229E,Table 2,Case 237,,,US,HCov-229E,NT,Neutralizing,Titre,>32,,4,38,month,FALSE,,,
4626012,antibody titer to 229E,Table 2,Case 531,,,US,HCov-229E,NT,Neutralizing,Titre,<4,,4,Pre,Categorical,FALSE,,,
4626012,antibody titer to 229E,Table 2,Case 531,,,US,HCov-229E,NT,Neutralizing,Titre,16,,4,Peak,Categorical,FALSE,,,
4626012,antibody titer to 229E,Table 2,Case 531,,,US,HCov-229E,NT,Neutralizing,Titre,8,,4,36,month,FALSE,,,
4626012,antibody titer to 229E,Table 2,Case 503,,,US,HCov-229E,NT,Neutralizing,Titre,<8,,4,Pre,Categorical,FALSE,,,
4626012,antibody titer to 229E,Table 2,Case 503,,,US,HCov-229E,NT,Neutralizing,Titre,32,,4,Peak,Categorical,FALSE,,,
4626012,antibody titer to 229E,Table 2,Case 503,,,US,HCov-229E,NT,Neutralizing,Titre,16,,4,38,month,FALSE,,,
4626012,antibody titer to 229E,Table 2,Case 459,,,US,HCov-229E,NT,Neutralizing,Titre,16,,4,Pre,Categorical,FALSE,,,
4626012,antibody titer to 229E,Table 2,Case 459,,,US,HCov-229E,NT,Neutralizing,Titre,64,,4,Peak,Categorical,FALSE,,,
4626012,antibody titer to 229E,Table 2,Case 459,,,US,HCov-229E,NT,Neutralizing,Titre,32,,4,34,month,FALSE,,,
4626012,antibody titer to 229E,Table 2,Case 516,,,US,HCov-229E,NT,Neutralizing,Titre,8,,4,Pre,Categorical,FALSE,,,
4626012,antibody titer to 229E,Table 2,Case 516,,,US,HCov-229E,NT,Neutralizing,Titre,>=128,,4,Peak,Categorical,FALSE,,,
4626012,antibody titer to 229E,Table 2,Case 516,,,US,HCov-229E,NT,Neutralizing,Titre,>=64,,4,41,month,FALSE,,,
4626012,antibody titer to 229E,Table 2,Case 535,,,US,HCov-229E,NT,Neutralizing,Titre,16,,4,Pre,Categorical,FALSE,,,
4626012,antibody titer to 229E,Table 2,Case 535,,,US,HCov-229E,NT,Neutralizing,Titre,>=128,,4,Peak,Categorical,FALSE,,,
4626012,antibody titer to 229E,Table 2,Case 535,,,US,HCov-229E,NT,Neutralizing,Titre,32,,4,26,month,FALSE,,,
4626012,antibody titer to 229E,Table 2,Case 532,,,US,HCov-229E,NT,Neutralizing,Titre,4,,4,Pre,Categorical,FALSE,,,
4626012,antibody titer to 229E,Table 2,Case 532,,,US,HCov-229E,NT,Neutralizing,Titre,32,,4,Peak,Categorical,FALSE,,,
4626012,antibody titer to 229E,Table 2,Case 532,,,US,HCov-229E,NT,Neutralizing,Titre,16,,4,39,month,FALSE,,,
4626012,antibody titer to 229E,Table 2,Case 505,,,US,HCov-229E,NT,Neutralizing,Titre,8,,4,Pre,Categorical,FALSE,,,
4626012,antibody titer to 229E,Table 2,Case 505,,,US,HCov-229E,NT,Neutralizing,Titre,>=128,,4,Peak,Categorical,FALSE,,,
4626012,antibody titer to 229E,Table 2,Case 505,,,US,HCov-229E,NT,Neutralizing,Titre,8,,4,47,month,FALSE,,,
4626012,antibody titer to 229E,Table 2,Case 515,,,US,HCov-229E,NT,Neutralizing,Titre,16,,4,Pre,Categorical,FALSE,,,
4626012,antibody titer to 229E,Table 2,Case 515,,,US,HCov-229E,NT,Neutralizing,Titre,>=128,,4,Peak,Categorical,FALSE,,,
4626012,antibody titer to 229E,Table 2,Case 515,,,US,HCov-229E,NT,Neutralizing,Titre,>=64,,4,36,month,FALSE,,,
4626012,antibody titer to 229E,Table 2,Case 453,,,US,HCov-229E,NT,Neutralizing,Titre,8,,4,Pre,Categorical,FALSE,,,
4626012,antibody titer to 229E,Table 2,Case 453,,,US,HCov-229E,NT,Neutralizing,Titre,>=64,,4,Peak,Categorical,FALSE,,,
4626012,antibody titer to 229E,Table 2,Case 453,,,US,HCov-229E,NT,Neutralizing,Titre,16,,4,26,month,FALSE,,,
4626012,antibody titer to 229E,Table 2,Case 486,,,US,HCov-229E,NT,Neutralizing,Titre,4,,4,Pre,Categorical,FALSE,,,
4626012,antibody titer to 229E,Table 2,Case 486,,,US,HCov-229E,NT,Neutralizing,Titre,16,,4,Peak,Categorical,FALSE,,,
4626012,antibody titer to 229E,Table 2,Case 486,,,US,HCov-229E,NT,Neutralizing,Titre,16,,4,48,month,FALSE,,,
4626012,antibody titer to 229E,Table 2,Case 498,,,US,HCov-229E,NT,Neutralizing,Titre,8,,4,Pre,Categorical,FALSE,,,
4626012,antibody titer to 229E,Table 2,Case 498,,,US,HCov-229E,NT,Neutralizing,Titre,32,,4,Peak,Categorical,FALSE,,,
4626012,antibody titer to 229E,Table 2,Case 498,,,US,HCov-229E,NT,Neutralizing,Titre,16,,4,33,month,FALSE,,,
6244598,Primary infection; acute,Table 2 ,Patient 338,4,,US,HCov-OC43,PRA,IgG,Titre,<10,,10,0,day,FALSE,,,
6244598,Primary infection; convalescent,Table 2 ,Patient 338,4,,US,HCov-OC43,PRA,IgG,Titre,80,,10,15,day,FALSE,,,
6244598,Primary infection; acute,Table 2 ,Patient 467,0.333333333,,US,HCov-OC43,PRA,IgG,Titre,40,,10,0,day,FALSE,,,
6244598,Primary infection; convalescent,Table 2 ,Patient 467,0.333333333,,US,HCov-OC43,PRA,IgG,Titre,160,,10,30,day,FALSE,,,
6244598,Primary infection; acute,Table 2 ,Patient 510,0.75,,US,HCov-OC43,PRA,IgG,Titre,<10,,10,0,day,FALSE,,,
6244598,Primary infection; convalescent,Table 2 ,Patient 510,0.75,,US,HCov-OC43,PRA,IgG,Titre,80,,10,28,day,FALSE,,,
6244598,Primary infection; acute,Table 2 ,Patient 532,4,,US,HCov-OC43,PRA,IgG,Titre,<10,,10,0,day,FALSE,,,
6244598,Primary infection; convalescent,Table 2 ,Patient 532,4,,US,HCov-OC43,PRA,IgG,Titre,640,,10,13,day,FALSE,,,
6244598,Reinfection; acute,Table 2 ,Patient 291,12,,US,HCov-OC43,PRA,IgG,Titre,40,,10,0,day,FALSE,,,
6244598,Reinfection; acute,Table 2 ,Patient 440,3,,US,HCov-OC43,PRA,IgG,Titre,320,,10,0,day,FALSE,,,
6244598,Reinfection; convalescent,Table 2 ,Patient 440,3,,US,HCov-OC43,PRA,IgG,Titre,2560,,10,26,day,FALSE,,,
6244598,Reinfection; acute,Table 2 ,Patient 768,4,,US,HCov-OC43,PRA,IgG,Titre,20,,10,0,day,FALSE,,,
6244598,Reinfection; convalescent,Table 2 ,Patient 768,4,,US,HCov-OC43,PRA,IgG,Titre,320,,10,27,day,FALSE,,,
6244598,Primary infection; acute,Table 2 ,Patient 338,4,,US,HCov-OC43,HI,IgG,Titre,<10,,10,0,day,FALSE,,,
6244598,Primary infection; convalescent,Table 2 ,Patient 338,4,,US,HCov-OC43,HI,IgG,Titre,20,,10,15,day,FALSE,,,
6244598,Primary infection; acute,Table 2 ,Patient 467,0.333333333,,US,HCov-OC43,HI,IgG,Titre,<10,,10,0,day,FALSE,,,
6244598,Primary infection; convalescent,Table 2 ,Patient 467,0.333333333,,US,HCov-OC43,HI,IgG,Titre,20,,10,30,day,FALSE,,,
6244598,Primary infection; acute,Table 2 ,Patient 510,0.75,,US,HCov-OC43,HI,IgG,Titre,<10,,10,0,day,FALSE,,,
6244598,Primary infection; convalescent,Table 2 ,Patient 510,0.75,,US,HCov-OC43,HI,IgG,Titre,20,,10,28,day,FALSE,,,
6244598,Primary infection; acute,Table 2 ,Patient 532,4,,US,HCov-OC43,HI,IgG,Titre,<10,,10,0,day,FALSE,,,
6244598,Primary infection; convalescent,Table 2 ,Patient 532,4,,US,HCov-OC43,HI,IgG,Titre,80,,10,13,day,FALSE,,,
6244598,Reinfection; acute,Table 2 ,Patient 291,12,,US,HCov-OC43,HI,IgG,Titre,10,,10,0,day,FALSE,,,
6244598,Reinfection; acute,Table 2 ,Patient 440,3,,US,HCov-OC43,HI,IgG,Titre,20,,10,0,day,FALSE,,,
6244598,Reinfection; convalescent,Table 2 ,Patient 440,3,,US,HCov-OC43,HI,IgG,Titre,160,,10,26,day,FALSE,,,
6244598,Reinfection; acute,Table 2 ,Patient 768,4,,US,HCov-OC43,HI,IgG,Titre,40,,10,0,day,FALSE,,,
6244598,Reinfection; convalescent,Table 2 ,Patient 768,4,,US,HCov-OC43,HI,IgG,Titre,160,,10,27,day,FALSE,,,
6244598,Primary infection; acute,Table 2 ,Patient 338,4,,US,HCov-OC43,IPA-IgG,IgG,Titre,<10,,10,0,day,FALSE,,,
6244598,Primary infection; convalescent,Table 2 ,Patient 338,4,,US,HCov-OC43,IPA-IgG,IgG,Titre,40,,10,15,day,FALSE,,,
6244598,Primary infection; acute,Table 2 ,Patient 467,0.333333333,,US,HCov-OC43,IPA-IgG,IgG,Titre,<10,,10,0,day,FALSE,,,
6244598,Primary infection; convalescent,Table 2 ,Patient 467,0.333333333,,US,HCov-OC43,IPA-IgG,IgG,Titre,40,,10,30,day,FALSE,,,
6244598,Primary infection; acute,Table 2 ,Patient 510,0.75,,US,HCov-OC43,IPA-IgG,IgG,Titre,<10,,10,0,day,FALSE,,,
6244598,Primary infection; convalescent,Table 2 ,Patient 510,0.75,,US,HCov-OC43,IPA-IgG,IgG,Titre,160,,10,28,day,FALSE,,,
6244598,Primary infection; acute,Table 2 ,Patient 532,4,,US,HCov-OC43,IPA-IgG,IgG,Titre,<10,,10,0,day,FALSE,,,
6244598,Primary infection; convalescent,Table 2 ,Patient 532,4,,US,HCov-OC43,IPA-IgG,IgG,Titre,40,,10,13,day,FALSE,,,
6244598,Reinfection; acute,Table 2 ,Patient 291,12,,US,HCov-OC43,IPA-IgG,IgG,Titre,10,,10,0,day,FALSE,,,
6244598,Reinfection; acute,Table 2 ,Patient 440,3,,US,HCov-OC43,IPA-IgG,IgG,Titre,40,,10,0,day,FALSE,,,
6244598,Reinfection; convalescent,Table 2 ,Patient 440,3,,US,HCov-OC43,IPA-IgG,IgG,Titre,640,,10,27,day,FALSE,,,
6244598,Reinfection; acute,Table 2 ,Patient 768,4,,US,HCov-OC43,IPA-IgG,IgG,Titre,40,,10,0,day,FALSE,,,
6244598,Reinfection; convalescent,Table 2 ,Patient 768,4,,US,HCov-OC43,IPA-IgG,IgG,Titre,160,,10,27,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1 ,1,23,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,8,,8,4,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1 ,1,23,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.012,,0.15,4,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,1,23,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,512,,8,22,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,1,23,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.601,,0.15,22,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,2,42,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,<8,,8,5,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,2,42,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.001,,0.15,5,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,2,42,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,512,,8,26,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,2,42,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.834,,0.15,26,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,3,21,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,128,,8,11,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,3,21,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.348,,0.15,11,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,3,21,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,256,,8,16,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,3,21,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.949,,0.15,16,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,4,35,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,<8,,8,11,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,4,35,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.334,,0.15,11,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,4,35,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,64,,8,37,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,4,35,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,1.104,,0.15,37,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,5,47,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,32,,8,3,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,5,47,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.113,,0.15,3,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,5,47,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,256,,8,17,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,5,47,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.635,,0.15,17,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,6,72,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,8,,8,4,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,6,72,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.251,,0.15,4,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,6,72,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,1024,,8,27,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,6,72,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,1.11,,0.15,27,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,7,34,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,<8,,8,5,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,7,34,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.025,,0.15,5,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,7,34,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,256,,8,26,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,7,34,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.535,,0.15,26,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,8,37,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,8,,8,3,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,8,37,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.278,,0.15,3,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,8,37,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,512,,8,24,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,8,37,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.751,,0.15,24,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,9,30,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,<8,,8,3,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,9,30,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.118,,0.15,3,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,9,30,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,512,,8,28,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,9,30,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.911,,0.15,28,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,10,23,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,<8,,8,4,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,10,23,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.033,,0.15,4,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,10,23,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,64,,8,20,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,10,23,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.468,,0.15,20,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,11,38,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,<8,,8,9,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,11,38,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.006,,0.15,9,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,11,38,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,64,,8,16,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,11,38,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.317,,0.15,16,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,12,42,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,<8,,8,3,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,12,42,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.003,,0.15,3,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,12,42,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,512,,8,20,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,12,42,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.643,,0.15,20,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,13,51,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,<8,,8,3,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,13,51,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.018,,0.15,3,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,13,51,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,256,,8,16,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,13,51,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,1.056,,0.15,16,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,14,77,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,32,,8,3,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,14,77,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.049,,0.15,3,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,14,77,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,1024,,8,25,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,14,77,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.861,,0.15,25,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,15,55,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,64,,8,7,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,15,55,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.105,,0.15,7,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,15,55,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,512,,8,26,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,15,55,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,1.148,,0.15,26,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,16,41,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,16,,8,11,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,16,41,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.305,,0.15,11,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,16,41,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,128,,8,32,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,16,41,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.635,,0.15,32,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,17,14,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,16,,8,3,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,17,14,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.035,,0.15,3,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,17,14,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,128,,8,26,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,17,14,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,1.028,,0.15,26,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,18,39,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,<8,,8,8,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,18,39,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.001,,0.15,8,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,18,39,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,256,,8,22,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,18,39,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.437,,0.15,22,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,19,48,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,<8,,8,5,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,19,48,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.01,,0.15,5,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,19,48,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,1024,,8,26,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,19,48,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.752,,0.15,26,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,20,70,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,64,,8,9,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,20,70,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.284,,0.15,9,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,20,70,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,1024,,8,39,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,20,70,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,1.32,,0.15,39,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,21,43,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,8,,8,4,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,21,43,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.001,,0.15,4,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,21,43,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,1024,,8,18,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,21,43,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.296,,0.15,18,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,22,53,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,1024,,8,14,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,22,53,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.079,,0.15,14,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,22,53,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,1024,,8,27,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,22,53,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,1.179,,0.15,27,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,23,18,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,512,,8,1,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,23,18,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.135,,0.15,1,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,23,18,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,1024,,8,20,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,23,18,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.876,,0.15,20,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,24,51,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,256,,8,10,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,24,51,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.059,,0.15,10,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,24,51,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,512,,8,50,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,24,51,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.912,,0.15,50,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,25,24,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,<8,,8,3,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,25,24,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.005,,0.15,3,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,25,24,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,256,,8,20,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,25,24,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.337,,0.15,20,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,26,12,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,<8,,8,5,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,26,12,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.008,,0.15,5,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,26,12,,Taiwan,SARS-CoV-1,NT,Neutralizing,Titre,128,,8,27,day,FALSE,,,
16173022,Paired sera for 26 patients associated w SARS,Table 1,26,12,,Taiwan,SARS-CoV-1,ELISA,IgG,OD,0.923,,0.15,27,day,FALSE,,,
15031782,Cumulate number of cases,Figure 1B,,,,China,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,3,day,TRUE,0,36,
15031782,Cumulate number of cases,Figure 1B,,,,China,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,6,day,TRUE,1,36,
15031782,Cumulate number of cases,Figure 1B,,,,China,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,9,day,TRUE,5,36,
15031782,Cumulate number of cases,Figure 1B,,,,China,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,12,day,TRUE,7,36,
15031782,Cumulate number of cases,Figure 1B,,,,China,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,15,day,TRUE,14,36,
15031782,Cumulate number of cases,Figure 1B,,,,China,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,18,day,TRUE,17,36,
15031782,Cumulate number of cases,Figure 1B,,,,China,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,21,day,TRUE,27,36,
15031782,Cumulate number of cases,Figure 1B,,,,China,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,24,day,TRUE,27,36,
15031782,Cumulate number of cases,Figure 1B,,,,China,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,27,day,TRUE,27,36,
15031782,Cumulate number of cases,Figure 1B,,,,China,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,30,day,TRUE,27,36,
15031782,Cumulate number of cases,Figure 1B,,,,China,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,37,day,TRUE,28,36,
15031782,Cumulate number of cases,Figure 1B,,,,China,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,44,day,TRUE,29,36,
15031782,Cumulate number of cases,Figure 1B,,,,China,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,51,day,TRUE,30,36,
15031782,Cumulate number of cases,Figure 1B,,,,China,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,60,day,TRUE,30,36,
15031782,Cumulate number of cases,Figure 1B,,,,China,SARS-CoV-1,ELISA,IgM,Cumulative proportion,,,,3,day,TRUE,1,36,
15031782,Cumulate number of cases,Figure 1B,,,,China,SARS-CoV-1,ELISA,IgM,Cumulative proportion,,,,6,day,TRUE,3,36,
15031782,Cumulate number of cases,Figure 1B,,,,China,SARS-CoV-1,ELISA,IgM,Cumulative proportion,,,,9,day,TRUE,5,36,
15031782,Cumulate number of cases,Figure 1B,,,,China,SARS-CoV-1,ELISA,IgM,Cumulative proportion,,,,12,day,TRUE,5,36,
15031782,Cumulate number of cases,Figure 1B,,,,China,SARS-CoV-1,ELISA,IgM,Cumulative proportion,,,,15,day,TRUE,7,36,
15031782,Cumulate number of cases,Figure 1B,,,,China,SARS-CoV-1,ELISA,IgM,Cumulative proportion,,,,18,day,TRUE,16,36,
15031782,Cumulate number of cases,Figure 1B,,,,China,SARS-CoV-1,ELISA,IgM,Cumulative proportion,,,,21,day,TRUE,21,36,
15031782,Cumulate number of cases,Figure 1B,,,,China,SARS-CoV-1,ELISA,IgM,Cumulative proportion,,,,24,day,TRUE,21,36,
15031782,Cumulate number of cases,Figure 1B,,,,China,SARS-CoV-1,ELISA,IgM,Cumulative proportion,,,,27,day,TRUE,21,36,
15031782,Cumulate number of cases,Figure 1B,,,,China,SARS-CoV-1,ELISA,IgM,Cumulative proportion,,,,30,day,TRUE,21,36,
15031782,Cumulate number of cases,Figure 1B,,,,China,SARS-CoV-1,ELISA,IgM,Cumulative proportion,,,,37,day,TRUE,19,36,
15031782,Cumulate number of cases,Figure 1B,,,,China,SARS-CoV-1,ELISA,IgM,Cumulative proportion,,,,44,day,TRUE,18,36,
15031782,Cumulate number of cases,Figure 1B,,,,China,SARS-CoV-1,ELISA,IgM,Cumulative proportion,,,,51,day,TRUE,16,36,
15031782,Cumulate number of cases,Figure 1B,,,,China,SARS-CoV-1,ELISA,IgM,Cumulative proportion,,,,60,day,TRUE,16,36,
19396666,Cumulative numbers with seroconversion,Figure 1,,,,China,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,1,week,TRUE,0,67,
19396666,Cumulative numbers with seroconversion,Figure 1,,,,China,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,2,week,TRUE,15,67,
19396666,Cumulative numbers with seroconversion,Figure 1,,,,China,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,3,week,TRUE,31,67,
19396666,Cumulative numbers with seroconversion,Figure 1,,,,China,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,4,week,TRUE,44,67,
19396666,Cumulative numbers with seroconversion,Figure 1,,,,China,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,5,week,TRUE,52,67,
19396666,Cumulative numbers with seroconversion,Figure 1,,,,China,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,6,week,TRUE,66,67,
19396666,Cumulative numbers with seroconversion,Figure 1,,,,China,SARS-CoV-1,ELISA,IgM,Cumulative proportion,,,,1,week,TRUE,5,67,
19396666,Cumulative numbers with seroconversion,Figure 1,,,,China,SARS-CoV-1,ELISA,IgM,Cumulative proportion,,,,2,week,TRUE,27,67,
19396666,Cumulative numbers with seroconversion,Figure 1,,,,China,SARS-CoV-1,ELISA,IgM,Cumulative proportion,,,,3,week,TRUE,38,67,
19396666,Cumulative numbers with seroconversion,Figure 1,,,,China,SARS-CoV-1,ELISA,IgM,Cumulative proportion,,,,4,week,TRUE,59,67,
19396666,Cumulative numbers with seroconversion,Figure 1,,,,China,SARS-CoV-1,ELISA,IgM,Cumulative proportion,,,,5,week,TRUE,52,67,
19396666,Cumulative numbers with seroconversion,Figure 1,,,,China,SARS-CoV-1,ELISA,IgM,Cumulative proportion,,,,6,week,TRUE,38,67,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgG,Cumulative proportion,,,,0,days,TRUE,0,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgG,Cumulative proportion,,,,1,days,TRUE,0,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgG,Cumulative proportion,,,,2,days,TRUE,0,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgG,Cumulative proportion,,,,3,days,TRUE,0,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgG,Cumulative proportion,,,,4,days,TRUE,2,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgG,Cumulative proportion,,,,5,days,TRUE,3,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgG,Cumulative proportion,,,,6,days,TRUE,3,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgG,Cumulative proportion,,,,7,days,TRUE,5,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgG,Cumulative proportion,,,,8,days,TRUE,9,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgG,Cumulative proportion,,,,9,days,TRUE,13,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgG,Cumulative proportion,,,,10,days,TRUE,20,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgG,Cumulative proportion,,,,11,days,TRUE,22,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgG,Cumulative proportion,,,,12,days,TRUE,25,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgG,Cumulative proportion,,,,13,days,TRUE,27,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgG,Cumulative proportion,,,,14,days,TRUE,29,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgG,Cumulative proportion,,,,15,days,TRUE,29,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgG,Cumulative proportion,,,,16,days,TRUE,29,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgG,Cumulative proportion,,,,17,days,TRUE,29,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgG,Cumulative proportion,,,,18,days,TRUE,29,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgG,Cumulative proportion,,,,19,days,TRUE,30,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgG,Cumulative proportion,,,,20,days,TRUE,30,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgG,Cumulative proportion,,,,21,days,TRUE,30,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgA,Cumulative proportion,,,,0,days,TRUE,0,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgA,Cumulative proportion,,,,1,days,TRUE,0,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgA,Cumulative proportion,,,,2,days,TRUE,0,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgA,Cumulative proportion,,,,3,days,TRUE,0,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgA,Cumulative proportion,,,,4,days,TRUE,1,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgA,Cumulative proportion,,,,5,days,TRUE,0,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgA,Cumulative proportion,,,,6,days,TRUE,2,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgA,Cumulative proportion,,,,7,days,TRUE,3,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgA,Cumulative proportion,,,,8,days,TRUE,5,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgA,Cumulative proportion,,,,9,days,TRUE,7,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgA,Cumulative proportion,,,,10,days,TRUE,11,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgA,Cumulative proportion,,,,11,days,TRUE,15,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgA,Cumulative proportion,,,,12,days,TRUE,20,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgA,Cumulative proportion,,,,13,days,TRUE,23,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgA,Cumulative proportion,,,,14,days,TRUE,26,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgA,Cumulative proportion,,,,15,days,TRUE,28,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgA,Cumulative proportion,,,,16,days,TRUE,30,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgA,Cumulative proportion,,,,17,days,TRUE,30,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgA,Cumulative proportion,,,,18,days,TRUE,30,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgA,Cumulative proportion,,,,19,days,TRUE,30,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgA,Cumulative proportion,,,,20,days,TRUE,30,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgA,Cumulative proportion,,,,21,days,TRUE,30,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgM,Cumulative proportion,,,,0,days,TRUE,0,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgM,Cumulative proportion,,,,1,days,TRUE,0,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgM,Cumulative proportion,,,,2,days,TRUE,0,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgM,Cumulative proportion,,,,3,days,TRUE,0,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgM,Cumulative proportion,,,,4,days,TRUE,1,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgM,Cumulative proportion,,,,5,days,TRUE,0,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgM,Cumulative proportion,,,,6,days,TRUE,1,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgM,Cumulative proportion,,,,7,days,TRUE,2,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgM,Cumulative proportion,,,,8,days,TRUE,5,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgM,Cumulative proportion,,,,9,days,TRUE,7,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgM,Cumulative proportion,,,,10,days,TRUE,10,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgM,Cumulative proportion,,,,11,days,TRUE,15,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgM,Cumulative proportion,,,,12,days,TRUE,20,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgM,Cumulative proportion,,,,13,days,TRUE,25,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgM,Cumulative proportion,,,,14,days,TRUE,26,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgM,Cumulative proportion,,,,15,days,TRUE,28,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgM,Cumulative proportion,,,,16,days,TRUE,28,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgM,Cumulative proportion,,,,17,days,TRUE,29,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgM,Cumulative proportion,,,,18,days,TRUE,29,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgM,Cumulative proportion,,,,19,days,TRUE,30,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgM,Cumulative proportion,,,,20,days,TRUE,30,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (a),,,,,SARS-CoV-1,IFA,IgM,Cumulative proportion,,,,21,days,TRUE,30,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (b),,,,,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,0,days,TRUE,0,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (b),,,,,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,1,days,TRUE,0,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (b),,,,,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,2,days,TRUE,0,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (b),,,,,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,3,days,TRUE,0,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (b),,,,,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,4,days,TRUE,2,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (b),,,,,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,5,days,TRUE,2,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (b),,,,,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,6,days,TRUE,2,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (b),,,,,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,7,days,TRUE,2,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (b),,,,,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,8,days,TRUE,6,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (b),,,,,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,9,days,TRUE,11,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (b),,,,,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,10,days,TRUE,12,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (b),,,,,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,11,days,TRUE,15,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (b),,,,,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,12,days,TRUE,16,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (b),,,,,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,13,days,TRUE,22,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (b),,,,,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,14,days,TRUE,25,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (b),,,,,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,15,days,TRUE,25,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (b),,,,,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,16,days,TRUE,27,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (b),,,,,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,17,days,TRUE,27,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (b),,,,,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,18,days,TRUE,30,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (b),,,,,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,19,days,TRUE,30,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (b),,,,,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,20,days,TRUE,30,30,
15606632,Cumulative number of patients seroconverted,Figure 1 (b),,,,,SARS-CoV-1,ELISA,IgG,Cumulative proportion,,,,21,days,TRUE,30,30,
16275947,,Fig.1A,Patient 16,,,China (HK),SARS-CoV-1,IFA,IgGAM,Titre,1,,,5,Day,FALSE,,,
16275947,,Fig.1A,Patient 16,,,China (HK),SARS-CoV-1,IFA,IgGAM,Titre,1,,,9,Day,FALSE,,,
16275947,,Fig.1A,Patient 16,,,China (HK),SARS-CoV-1,IFA,IgGAM,Titre,1,,,13,Day,FALSE,,,
16275947,,Fig.1A,Patient 16,,,China (HK),SARS-CoV-1,IFA,IgGAM,Titre,179.7855821,,,16,Day,FALSE,,,
16275947,,Fig.1A,Patient 16,,,China (HK),SARS-CoV-1,IFA,IgGAM,Titre,693.8943033,,,19,Day,FALSE,,,
16275947,,Fig.1A,Patient 16,,,China (HK),SARS-CoV-1,IFA,IgGAM,Titre,709.2560403,,,22,Day,FALSE,,,
16275947,,Fig.1A,Patient 16,,,China (HK),SARS-CoV-1,IFA,IgGAM,Titre,725.1342654,,,23,Day,FALSE,,,
16275947,,Fig.1A,Patient 16,,,China (HK),SARS-CoV-1,IFA,IgGAM,Titre,741.3679588,,,28,Day,FALSE,,,
16275947,,Fig.1A,Patient 16,,,China (HK),HCoV-OC43,IFA,IgG,Titre,41.70032847,,,5,Day,FALSE,,,
16275947,,Fig.1A,Patient 16,,,China (HK),HCoV-OC43,IFA,IgG,Titre,81.02163714,,,9,Day,FALSE,,,
16275947,,Fig.1A,Patient 16,,,China (HK),HCoV-OC43,IFA,IgG,Titre,42.65463084,,,13,Day,FALSE,,,
16275947,,Fig.1A,Patient 16,,,China (HK),HCoV-OC43,IFA,IgG,Titre,42.6338802,,,16,Day,FALSE,,,
16275947,,Fig.1A,Patient 16,,,China (HK),HCoV-OC43,IFA,IgG,Titre,90.50611799,,,19,Day,FALSE,,,
16275947,,Fig.1A,Patient 16,,,China (HK),HCoV-OC43,IFA,IgG,Titre,88.50277522,,,22,Day,FALSE,,,
16275947,,Fig.1A,Patient 16,,,China (HK),HCoV-OC43,IFA,IgG,Titre,192.0858399,,,23,Day,FALSE,,,
16275947,,Fig.1A,Patient 16,,,China (HK),HCoV-OC43,IFA,IgG,Titre,373.2131085,,,28,Day,FALSE,,,
16275947,,Fig.1A,Patient 16,,,China (HK),HCov-229E,IFA,IgG,Titre,19.21325799,,,5,Day,FALSE,,,
16275947,,Fig.1A,Patient 16,,,China (HK),HCov-229E,IFA,IgG,Titre,20.08803457,,,9,Day,FALSE,,,
16275947,,Fig.1A,Patient 16,,,China (HK),HCov-229E,IFA,IgG,Titre,40.79714338,,,13,Day,FALSE,,,
16275947,,Fig.1A,Patient 16,,,China (HK),HCov-229E,IFA,IgG,Titre,41.70032847,,,16,Day,FALSE,,,
16275947,,Fig.1A,Patient 16,,,China (HK),HCov-229E,IFA,IgG,Titre,84.68993189,,,19,Day,FALSE,,,
16275947,,Fig.1A,Patient 16,,,China (HK),HCov-229E,IFA,IgG,Titre,84.68993189,,,22,Day,FALSE,,,
16275947,,Fig.1A,Patient 16,,,China (HK),HCov-229E,IFA,IgG,Titre,88.50277522,,,23,Day,FALSE,,,
16275947,,Fig.1A,Patient 16,,,China (HK),HCov-229E,IFA,IgG,Titre,88.50277522,,,28,Day,FALSE,,,
16275947,,Fig.1A,Patient 16,,,China (HK),SARS-CoV-1,IFA,IgG,Titre,1,,,5,Day,FALSE,,,
16275947,,Fig.1A,Patient 16,,,China (HK),SARS-CoV-1,IFA,IgG,Titre,1,,,9,Day,FALSE,,,
16275947,,Fig.1A,Patient 16,,,China (HK),SARS-CoV-1,IFA,IgG,Titre,1,,,13,Day,FALSE,,,
16275947,,Fig.1A,Patient 16,,,China (HK),SARS-CoV-1,IFA,IgG,Titre,1,,,16,Day,FALSE,,,
16275947,,Fig.1A,Patient 16,,,China (HK),SARS-CoV-1,IFA,IgG,Titre,11.04628894,,,19,Day,FALSE,,,
16275947,,Fig.1A,Patient 16,,,China (HK),SARS-CoV-1,IFA,IgG,Titre,11.29358393,,,22,Day,FALSE,,,
16275947,,Fig.1A,Patient 16,,,China (HK),SARS-CoV-1,IFA,IgG,Titre,44.55330913,,,23,Day,FALSE,,,
16275947,,Fig.1A,Patient 16,,,China (HK),SARS-CoV-1,IFA,IgG,Titre,757.9650785,,,28,Day,FALSE,,,
16275947,,Fig.1A,Patient 16,,,China (HK),SARS-CoV-1,NT,Neutralizing,Titre,1.011008625,,,5,Day,FALSE,,,
16275947,,Fig.1A,Patient 16,,,China (HK),SARS-CoV-1,NT,Neutralizing,Titre,1.033642232,,,9,Day,FALSE,,,
16275947,,Fig.1A,Patient 16,,,China (HK),SARS-CoV-1,NT,Neutralizing,Titre,1.057039687,,,13,Day,FALSE,,,
16275947,,Fig.1A,Patient 16,,,China (HK),SARS-CoV-1,NT,Neutralizing,Titre,1.080440896,,,16,Day,FALSE,,,
16275947,,Fig.1A,Patient 16,,,China (HK),SARS-CoV-1,NT,Neutralizing,Titre,21.94820387,,,19,Day,FALSE,,,
16275947,,Fig.1A,Patient 16,,,China (HK),SARS-CoV-1,NT,Neutralizing,Titre,43.5883315,,,22,Day,FALSE,,,
16275947,,Fig.1A,Patient 16,,,China (HK),SARS-CoV-1,NT,Neutralizing,Titre,88.50277522,,,23,Day,FALSE,,,
16275947,,Fig.1A,Patient 16,,,China (HK),SARS-CoV-1,NT,Neutralizing,Titre,196.3860954,,,28,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),HCoV-NI63,IFA,IgG,Titre,389.4719549,,,15,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),HCoV-NI63,IFA,IgG,Titre,389.4719549,,,16,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),HCoV-NI63,IFA,IgG,Titre,2993.577295,,,19,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),HCoV-NI63,IFA,IgG,Titre,2993.577295,,,22,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),HCoV-NI63,IFA,IgG,Titre,1483.981789,,,29,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),HCoV-NI63,IFA,IgG,Titre,1483.981789,,,37,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),HCoV-NI63,IFA,IgG,Titre,1483.981789,,,87,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),HCoV-229E,IFA,IgG,Titre,305.9949687,,,15,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),HCoV-229E,IFA,IgG,Titre,630.9573445,,,16,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),HCoV-229E,IFA,IgG,Titre,1191.764587,,,19,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),HCoV-229E,IFA,IgG,Titre,1191.764587,,,22,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),HCoV-229E,IFA,IgG,Titre,590.7837912,,,29,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),HCoV-229E,IFA,IgG,Titre,603.8824119,,,37,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),HCoV-OC43,IFA,IgG,Titre,38.1024043,,,15,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),HCoV-OC43,IFA,IgG,Titre,82.0891416,,,16,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),HCoV-OC43,IFA,IgG,Titre,151.6884037,,,19,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),HCoV-OC43,IFA,IgG,Titre,319.7141846,,,22,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),HCoV-OC43,IFA,IgG,Titre,151.6884037,,,29,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),HCoV-OC43,IFA,IgG,Titre,151.6884037,,,37,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),SARS-CoV-1,IFA,IgGAM,Titre,1,,,4,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),SARS-CoV-1,IFA,IgGAM,Titre,1,,,15,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),SARS-CoV-1,IFA,IgGAM,Titre,39.81071706,,,16,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),SARS-CoV-1,IFA,IgGAM,Titre,148.3981789,,,19,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),SARS-CoV-1,IFA,IgGAM,Titre,148.3981789,,,22,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),SARS-CoV-1,IFA,IgGAM,Titre,148.3981789,,,29,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),SARS-CoV-1,IFA,IgGAM,Titre,590.7837912,,,37,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),SARS-CoV-1,IFA,IgGAM,Titre,590.7837912,,,87,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),SARS-CoV-1,IFA,IgG,Titre,1,,,4,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),SARS-CoV-1,IFA,IgG,Titre,1,,,15,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),SARS-CoV-1,IFA,IgG,Titre,39.81071706,,,16,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),SARS-CoV-1,IFA,IgG,Titre,39.81071706,,,19,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),SARS-CoV-1,IFA,IgG,Titre,38.94719549,,,22,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),SARS-CoV-1,IFA,IgG,Titre,151.6884037,,,29,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),SARS-CoV-1,IFA,IgG,Titre,151.6884037,,,37,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),SARS-CoV-1,IFA,IgG,Titre,148.3981789,,,87,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),SARS-CoV-1,NT,Neutralizing,Titre,1,,,4,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),SARS-CoV-1,NT,Neutralizing,Titre,1,,,15,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),SARS-CoV-1,NT,Neutralizing,Titre,1,,,16,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),SARS-CoV-1,NT,Neutralizing,Titre,20.6198601,,,19,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),SARS-CoV-1,NT,Neutralizing,Titre,82.0891416,,,22,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),SARS-CoV-1,NT,Neutralizing,Titre,80.30857221,,,29,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),SARS-CoV-1,NT,Neutralizing,Titre,78.56662459,,,37,Day,FALSE,,,
16275947,,Fig.1B,Patient 10,,,China (HK),SARS-CoV-1,NT,Neutralizing,Titre,78.56662459,,,87,Day,FALSE,,,
16275947,,Fig.1C,Patient 13,,,China (HK),HCoV-OC43,IFA,IgG,Titre,40.2961132,,,6,Day,FALSE,,,
16275947,,Fig.1C,Patient 13,,,China (HK),HCoV-OC43,IFA,IgG,Titre,40.2961132,,,9,Day,FALSE,,,
16275947,,Fig.1C,Patient 13,,,China (HK),HCoV-OC43,IFA,IgG,Titre,40.2961132,,,13,Day,FALSE,,,
16275947,,Fig.1C,Patient 13,,,China (HK),HCoV-OC43,IFA,IgG,Titre,40.2961132,,,16,Day,FALSE,,,
16275947,,Fig.1C,Patient 13,,,China (HK),HCoV-OC43,IFA,IgG,Titre,40.2961132,,,19,Day,FALSE,,,
16275947,,Fig.1C,Patient 13,,,China (HK),HCoV-OC43,IFA,IgG,Titre,80.88998164,,,22,Day,FALSE,,,
16275947,,Fig.1C,Patient 13,,,China (HK),HCoV-OC43,IFA,IgG,Titre,78.47599704,,,28,Day,FALSE,,,
16275947,,Fig.1C,Patient 13,,,China (HK),HCoV-229E,IFA,IgG,Titre,40.2961132,,,6,Day,FALSE,,,
16275947,,Fig.1C,Patient 13,,,China (HK),HCoV-229E,IFA,IgG,Titre,40.2961132,,,9,Day,FALSE,,,
16275947,,Fig.1C,Patient 13,,,China (HK),HCoV-229E,IFA,IgG,Titre,20.0738918,,,13,Day,FALSE,,,
16275947,,Fig.1C,Patient 13,,,China (HK),HCoV-229E,IFA,IgG,Titre,20.0738918,,,16,Day,FALSE,,,
16275947,,Fig.1C,Patient 13,,,China (HK),HCoV-229E,IFA,IgG,Titre,20.0738918,,,19,Day,FALSE,,,
16275947,,Fig.1C,Patient 13,,,China (HK),HCoV-229E,IFA,IgG,Titre,20.0738918,,,22,Day,FALSE,,,
16275947,,Fig.1C,Patient 13,,,China (HK),HCoV-229E,IFA,IgG,Titre,37.92690191,,,28,Day,FALSE,,,
16275947,,Fig.1C,Patient 13,,,China (HK),SARS-CoV-1,IFA,IgGAM,Titre,1,,,6,Day,FALSE,,,
16275947,,Fig.1C,Patient 13,,,China (HK),SARS-CoV-1,IFA,IgGAM,Titre,1,,,9,Day,FALSE,,,
16275947,,Fig.1C,Patient 13,,,China (HK),SARS-CoV-1,IFA,IgGAM,Titre,1,,,13,Day,FALSE,,,
16275947,,Fig.1C,Patient 13,,,China (HK),SARS-CoV-1,IFA,IgGAM,Titre,10.30760802,,,16,Day,FALSE,,,
16275947,,Fig.1C,Patient 13,,,China (HK),SARS-CoV-1,IFA,IgGAM,Titre,167.3725414,,,19,Day,FALSE,,,
16275947,,Fig.1C,Patient 13,,,China (HK),SARS-CoV-1,IFA,IgGAM,Titre,674.4462875,,,22,Day,FALSE,,,
16275947,,Fig.1C,Patient 13,,,China (HK),SARS-CoV-1,IFA,IgGAM,Titre,674.4462875,,,28,Day,FALSE,,,
16275947,,Fig.1C,Patient 13,,,China (HK),SARS-CoV-1,NT,Neutralizing,Titre,1,,,6,Day,FALSE,,,
16275947,,Fig.1C,Patient 13,,,China (HK),SARS-CoV-1,NT,Neutralizing,Titre,1,,,9,Day,FALSE,,,
16275947,,Fig.1C,Patient 13,,,China (HK),SARS-CoV-1,NT,Neutralizing,Titre,1,,,13,Day,FALSE,,,
16275947,,Fig.1C,Patient 13,,,China (HK),SARS-CoV-1,NT,Neutralizing,Titre,1,,,16,Day,FALSE,,,
16275947,,Fig.1C,Patient 13,,,China (HK),SARS-CoV-1,NT,Neutralizing,Titre,78.47599704,,,19,Day,FALSE,,,
16275947,,Fig.1C,Patient 13,,,China (HK),SARS-CoV-1,NT,Neutralizing,Titre,325.9551857,,,22,Day,FALSE,,,
16275947,,Fig.1C,Patient 13,,,China (HK),SARS-CoV-1,NT,Neutralizing,Titre,325.9551857,,,28,Day,FALSE,,,
16275947,,Fig.1C,Patient 13,,,China (HK),SARS-CoV-1,IFA,IgG,Titre,1,,,6,Day,FALSE,,,
16275947,,Fig.1C,Patient 13,,,China (HK),SARS-CoV-1,IFA,IgG,Titre,1,,,9,Day,FALSE,,,
16275947,,Fig.1C,Patient 13,,,China (HK),SARS-CoV-1,IFA,IgG,Titre,1,,,13,Day,FALSE,,,
16275947,,Fig.1C,Patient 13,,,China (HK),SARS-CoV-1,IFA,IgG,Titre,1,,,16,Day,FALSE,,,
16275947,,Fig.1C,Patient 13,,,China (HK),SARS-CoV-1,IFA,IgG,Titre,20.0738918,,,19,Day,FALSE,,,
16275947,,Fig.1C,Patient 13,,,China (HK),SARS-CoV-1,IFA,IgG,Titre,20.0738918,,,22,Day,FALSE,,,
16275947,,Fig.1C,Patient 13,,,China (HK),SARS-CoV-1,IFA,IgG,Titre,49.81595049,,,28,Day,FALSE,,,
17517191,Strain Z2-Y3; reemergent SARS case.,Fig.B,Case A,32,M,China,SARS-CoV-1,NT,Neutralizing,Titre,20,,,8,Days,FALSE,,,
17517191,Strain Z2-Y3; reemergent SARS case.,Fig.B,Case A,32,M,China,SARS-CoV-1,NT,Neutralizing,Titre,30,,,10,Days,FALSE,,,
17517191,Strain Z2-Y3; reemergent SARS case.,Fig.B,Case A,32,M,China,SARS-CoV-1,NT,Neutralizing,Titre,160,,,13,Days,FALSE,,,
17517191,Strain Z2-Y3; reemergent SARS case.,Fig.B,Case A,32,M,China,SARS-CoV-1,NT,Neutralizing,Titre,120,,,18,Days,FALSE,,,
17517191,Strain Z2-Y3; reemergent SARS case.,Fig.B,Case A,32,M,China,SARS-CoV-1,NT,Neutralizing,Titre,80,,,21,Days,FALSE,,,
17517191,Strain Z2-Y3; reemergent SARS case.,Fig.B,Case B,20,F,China,SARS-CoV-1,NT,Neutralizing,Titre,80,,,10,Days,FALSE,,,
17517191,Strain Z2-Y3; reemergent SARS case.,Fig.B,Case B,20,F,China,SARS-CoV-1,NT,Neutralizing,Titre,160,,,11,Days,FALSE,,,
17517191,Strain Z2-Y3; reemergent SARS case.,Fig.B,Case B,20,F,China,SARS-CoV-1,NT,Neutralizing,Titre,640,,,13,Days,FALSE,,,
17517191,Strain Z2-Y3; reemergent SARS case.,Fig.B,Case B,20,F,China,SARS-CoV-1,NT,Neutralizing,Titre,240,,,18,Days,FALSE,,,
17517191,Strain Z2-Y3; reemergent SARS case.,Fig.B,Case C,35,M,China,SARS-CoV-1,NT,Neutralizing,Titre,120,,,7,Days,FALSE,,,
17517191,Strain Z2-Y3; reemergent SARS case.,Fig.B,Case C,35,M,China,SARS-CoV-1,NT,Neutralizing,Titre,120,,,8,Days,FALSE,,,
17517191,Strain Z2-Y3; reemergent SARS case.,Fig.B,Case C,35,M,China,SARS-CoV-1,NT,Neutralizing,Titre,640,,,11,Days,FALSE,,,
17517191,Strain Z2-Y3; reemergent SARS case.,Fig.B,Case C,35,M,China,SARS-CoV-1,NT,Neutralizing,Titre,640,,,19,Days,FALSE,,,
17517191,Strain Z2-Y3; reemergent SARS case.,Fig.B,Case C,35,M,China,SARS-CoV-1,NT,Neutralizing,Titre,240,,,22,Days,FALSE,,,
17517191,Strain Z2-Y3; reemergent SARS case.,Fig.B,Case D,40,M,China,SARS-CoV-1,NT,Neutralizing,Titre,80,,,6,Days,FALSE,,,
17517191,Strain Z2-Y3; reemergent SARS case.,Fig.B,Case D,40,M,China,SARS-CoV-1,NT,Neutralizing,Titre,160,,,7,Days,FALSE,,,
17517191,Strain Z2-Y3; reemergent SARS case.,Fig.B,Case D,40,M,China,SARS-CoV-1,NT,Neutralizing,Titre,160,,,8,Days,FALSE,,,
17517191,Strain Z2-Y3; reemergent SARS case.,Fig.B,Case D,40,M,China,SARS-CoV-1,NT,Neutralizing,Titre,160,,,9,Days,FALSE,,,
17517191,Strain Z2-Y3; reemergent SARS case.,Fig.B,Case D,40,M,China,SARS-CoV-1,NT,Neutralizing,Titre,320,,,10,Days,FALSE,,,
17517191,Strain Z2-Y3; reemergent SARS case.,Fig.B,Case D,40,M,China,SARS-CoV-1,NT,Neutralizing,Titre,320,,,11,Days,FALSE,,,
17517191,Strain Z2-Y3; reemergent SARS case.,Fig.B,Case D,40,M,China,SARS-CoV-1,NT,Neutralizing,Titre,480,,,12,Days,FALSE,,,
17517191,Strain Z2-Y3; reemergent SARS case.,Fig.B,Case D,40,M,China,SARS-CoV-1,NT,Neutralizing,Titre,480,,,13,Days,FALSE,,,
17517191,Strain Z2-Y3; reemergent SARS case.,Fig.B,Case D,40,M,China,SARS-CoV-1,NT,Neutralizing,Titre,320,,,14,Days,FALSE,,,
17517191,Strain Z2-Y3; reemergent SARS case.,Fig.B,Case D,40,M,China,SARS-CoV-1,NT,Neutralizing,Titre,160,,,16,Days,FALSE,,,
17517191,Strain F69; reemergent SARS case.,Fig.C,Case A,32,M,China,SARS-CoV-1,NT,Neutralizing,Titre,10,,,6,Days,FALSE,,,
17517191,Strain F69; reemergent SARS case.,Fig.C,Case A,32,M,China,SARS-CoV-1,NT,Neutralizing,Titre,10,,,8,Days,FALSE,,,
17517191,Strain F69; reemergent SARS case.,Fig.C,Case A,32,M,China,SARS-CoV-1,NT,Neutralizing,Titre,20,,,10,Days,FALSE,,,
17517191,Strain F69; reemergent SARS case.,Fig.C,Case A,32,M,China,SARS-CoV-1,NT,Neutralizing,Titre,160,,,13,Days,FALSE,,,
17517191,Strain F69; reemergent SARS case.,Fig.C,Case A,32,M,China,SARS-CoV-1,NT,Neutralizing,Titre,160,,,18,Days,FALSE,,,
17517191,Strain F69; reemergent SARS case.,Fig.C,Case A,32,M,China,SARS-CoV-1,NT,Neutralizing,Titre,80,,,21,Days,FALSE,,,
17517191,Strain F69; reemergent SARS case.,Fig.C,Case B,20,F,China,SARS-CoV-1,NT,Neutralizing,Titre,120,,,11,Days,FALSE,,,
17517191,Strain F69; reemergent SARS case.,Fig.C,Case B,20,F,China,SARS-CoV-1,NT,Neutralizing,Titre,320,,,13,Days,FALSE,,,
17517191,Strain F69; reemergent SARS case.,Fig.C,Case B,20,F,China,SARS-CoV-1,NT,Neutralizing,Titre,80,,,18,Days,FALSE,,,
17517191,Strain F69; reemergent SARS case.,Fig.C,Case C,35,M,China,SARS-CoV-1,NT,Neutralizing,Titre,10,,,6,Days,FALSE,,,
17517191,Strain F69; reemergent SARS case.,Fig.C,Case C,35,M,China,SARS-CoV-1,NT,Neutralizing,Titre,10,,,8,Days,FALSE,,,
17517191,Strain F69; reemergent SARS case.,Fig.C,Case C,35,M,China,SARS-CoV-1,NT,Neutralizing,Titre,20,,,10,Days,FALSE,,,
17517191,Strain F69; reemergent SARS case.,Fig.C,Case C,35,M,China,SARS-CoV-1,NT,Neutralizing,Titre,160,,,13,Days,FALSE,,,
17517191,Strain F69; reemergent SARS case.,Fig.C,Case C,35,M,China,SARS-CoV-1,NT,Neutralizing,Titre,160,,,18,Days,FALSE,,,
17517191,Strain F69; reemergent SARS case.,Fig.C,Case C,35,M,China,SARS-CoV-1,NT,Neutralizing,Titre,80,,,21,Days,FALSE,,,
17517191,Strain F69; reemergent SARS case.,Fig.C,Case D,40,M,China,SARS-CoV-1,NT,Neutralizing,Titre,40,,,6,Days,FALSE,,,
17517191,Strain F69; reemergent SARS case.,Fig.C,Case D,40,M,China,SARS-CoV-1,NT,Neutralizing,Titre,80,,,7,Days,FALSE,,,
17517191,Strain F69; reemergent SARS case.,Fig.C,Case D,40,M,China,SARS-CoV-1,NT,Neutralizing,Titre,80,,,8,Days,FALSE,,,
17517191,Strain F69; reemergent SARS case.,Fig.C,Case D,40,M,China,SARS-CoV-1,NT,Neutralizing,Titre,160,,,9,Days,FALSE,,,
17517191,Strain F69; reemergent SARS case.,Fig.C,Case D,40,M,China,SARS-CoV-1,NT,Neutralizing,Titre,240,,,10,Days,FALSE,,,
17517191,Strain F69; reemergent SARS case.,Fig.C,Case D,40,M,China,SARS-CoV-1,NT,Neutralizing,Titre,320,,,11,Days,FALSE,,,
17517191,Strain F69; reemergent SARS case.,Fig.C,Case D,40,M,China,SARS-CoV-1,NT,Neutralizing,Titre,320,,,12,Days,FALSE,,,
17517191,Strain F69; reemergent SARS case.,Fig.C,Case D,40,M,China,SARS-CoV-1,NT,Neutralizing,Titre,480,,,13,Days,FALSE,,,
17517191,Strain F69; reemergent SARS case.,Fig.C,Case D,40,M,China,SARS-CoV-1,NT,Neutralizing,Titre,240,,,14,Days,FALSE,,,
17517191,Strain F69; reemergent SARS case.,Fig.C,Case D,40,M,China,SARS-CoV-1,NT,Neutralizing,Titre,160,,,16,Days,FALSE,,,
18466680,,Table 3,Serum 1,,,China,SARS-CoV-1,ELISA,IgG?,OD (450 nm),0.423,,,30,Days,FALSE,,,
18466680,,Table 3,Serum 2,,,China,SARS-CoV-1,ELISA,IgG?,OD (450 nm),0.361,,,15,Days,FALSE,,,
18466680,,Table 3,Serum 3,,,China,SARS-CoV-1,ELISA,IgG?,OD (450 nm),0.487,,,12,Days,FALSE,,,
18466680,,Table 3,Serum 4,,,China,SARS-CoV-1,ELISA,IgG?,OD (450 nm),0.039,,,-10,Days,FALSE,,,
18466680,,Table 3,Serum 5,,,China,SARS-CoV-1,ELISA,IgG?,OD (450 nm),0.217,,,10,Days,FALSE,,,
18466680,,Table 3,Serum 6,,,China,SARS-CoV-1,ELISA,IgG?,OD (450 nm),0.197,,,-7,Days,FALSE,,,
18466680,,Table 3,Serum 7,,,China,SARS-CoV-1,ELISA,IgG?,OD (450 nm),0.208,,,-7,Days,FALSE,,,
18466680,,Table 3,Serum 8,,,China,SARS-CoV-1,ELISA,IgG?,OD (450 nm),0.128,,,7,Days,FALSE,,,
18466680,,Table 3,Serum 9,,,China,SARS-CoV-1,ELISA,IgG?,OD (450 nm),0.134,,,7,Days,FALSE,,,
18466680,,Table 3,Serum 10,,,China,SARS-CoV-1,ELISA,IgG?,OD (450 nm),0.121,,,3,Days,FALSE,,,
18466680,,Table 3,Serum 11,,,China,SARS-CoV-1,ELISA,IgG?,OD (450 nm),0.183,,,3,Days,FALSE,,,
18466680,,Table 3,Serum 12,,,China,SARS-CoV-1,ELISA,IgG?,OD (450 nm),0.175,,,2,Days,FALSE,,,
18466680,,Table 3,Serum 13,,,China,SARS-CoV-1,ELISA,IgG?,OD (450 nm),0.171,,,2,Days,FALSE,,,
18466680,,Table 3,Serum 14,,,China,SARS-CoV-1,ELISA,IgG?,OD (450 nm),0.229,,,2,Days,FALSE,,,
18466680,,Table 3,Serum 15,,,China,SARS-CoV-1,ELISA,IgG?,OD (450 nm),0.716,,,2,Days,FALSE,,,
18466680,,Table 3,Serum 16,,,China,SARS-CoV-1,ELISA,IgG?,OD (450 nm),0.147,,,2,Days,FALSE,,,
18466680,,Table 3,Serum 17,,,China,SARS-CoV-1,ELISA,IgG?,OD (450 nm),0.16,,,2,Days,FALSE,,,
18466680,,Table 3,Serum 18,,,China,SARS-CoV-1,ELISA,IgG?,OD (450 nm),0.225,,,2,Days,FALSE,,,
18466680,,Table 3,Serum 19,,,China,SARS-CoV-1,ELISA,IgG?,OD (450 nm),0.108,,,2,Days,FALSE,,,
18466680,,Table 3,Serum 20,,,China,SARS-CoV-1,ELISA,IgG?,OD (450 nm),0.328,,,1,Days,FALSE,,,
18466680,,Table 3,Serum 21,,,China,SARS-CoV-1,ELISA,IgG?,OD (450 nm),0.248,,,1,Days,FALSE,,,
18466680,,Table 3,Serum 22,,,China,SARS-CoV-1,ELISA,IgG?,OD (450 nm),0.184,,,1,Days,FALSE,,,
24896817,,Table 1,Serum sample 1,43,M,Saudi Arabia,MERS-CoV,IFA,,Titre,<10,,10,0,Days,FALSE,,,
24896817,,Table 1,Serum sample 2,43,M,Saudi Arabia,MERS-CoV,IFA,,Titre,1280,,10,14,Days,FALSE,,,
27109133,,Fig. 1A,Patient 1,,,China/South Korea,MERS-CoV,ELISA,IgG,OD (450 nm),0.004,,0.42,2,Days,FALSE,,,
27109133,,Fig. 1A,Patient 1,,,China/South Korea,MERS-CoV,ELISA,IgG,OD (450 nm),0.084,,0.42,3,Days,FALSE,,,
27109133,,Fig. 1A,Patient 1,,,China/South Korea,MERS-CoV,ELISA,IgG,OD (450 nm),0.18,,0.42,4,Days,FALSE,,,
27109133,,Fig. 1A,Patient 1,,,China/South Korea,MERS-CoV,ELISA,IgG,OD (450 nm),0.128,,0.42,5,Days,FALSE,,,
27109133,,Fig. 1A,Patient 1,,,China/South Korea,MERS-CoV,ELISA,IgG,OD (450 nm),0.196,,0.42,8,Days,FALSE,,,
27109133,,Fig. 1A,Patient 1,,,China/South Korea,MERS-CoV,ELISA,IgG,OD (450 nm),0.34,,0.42,9,Days,FALSE,,,
27109133,,Fig. 1A,Patient 1,,,China/South Korea,MERS-CoV,ELISA,IgG,OD (450 nm),0.384,,0.42,10,Days,FALSE,,,
27109133,,Fig. 1A,Patient 1,,,China/South Korea,MERS-CoV,ELISA,IgG,OD (450 nm),0.548,,0.42,13,Days,FALSE,,,
27109133,,Fig. 1A,Patient 1,,,China/South Korea,MERS-CoV,ELISA,IgG,OD (450 nm),0.708,,0.42,15,Days,FALSE,,,
27109133,,Fig. 1A,Patient 1,,,China/South Korea,MERS-CoV,ELISA,IgG,OD (450 nm),0.472,,0.42,18,Days,FALSE,,,
27109133,,Fig. 1A,Patient 1,,,China/South Korea,MERS-CoV,ELISA,IgG,OD (450 nm),0.444,,0.42,20,Days,FALSE,,,
27109133,,Fig. 1A,Patient 1,,,China/South Korea,MERS-CoV,ELISA,IgG,OD (450 nm),0.672,,0.42,27,Days,FALSE,,,
27109133,,Fig. 1A,Patient 1,,,China/South Korea,MERS-CoV,ELISA,IgG,OD (450 nm),0.796,,0.42,28,Days,FALSE,,,
27109133,,Fig. 1A,Patient 1,,,China/South Korea,MERS-CoV,ELISA,IgM,OD (450 nm),0.004,,0.32,2,Days,FALSE,,,
27109133,,Fig. 1A,Patient 1,,,China/South Korea,MERS-CoV,ELISA,IgM,OD (450 nm),0.056,,0.32,3,Days,FALSE,,,
27109133,,Fig. 1A,Patient 1,,,China/South Korea,MERS-CoV,ELISA,IgM,OD (450 nm),0.128,,0.32,4,Days,FALSE,,,
27109133,,Fig. 1A,Patient 1,,,China/South Korea,MERS-CoV,ELISA,IgM,OD (450 nm),0.1,,0.32,5,Days,FALSE,,,
27109133,,Fig. 1A,Patient 1,,,China/South Korea,MERS-CoV,ELISA,IgM,OD (450 nm),0.152,,0.32,8,Days,FALSE,,,
27109133,,Fig. 1A,Patient 1,,,China/South Korea,MERS-CoV,ELISA,IgM,OD (450 nm),0.32,,0.32,9,Days,FALSE,,,
27109133,,Fig. 1A,Patient 1,,,China/South Korea,MERS-CoV,ELISA,IgM,OD (450 nm),0.316,,0.32,10,Days,FALSE,,,
27109133,,Fig. 1A,Patient 1,,,China/South Korea,MERS-CoV,ELISA,IgM,OD (450 nm),0.464,,0.32,12,Days,FALSE,,,
27109133,,Fig. 1A,Patient 1,,,China/South Korea,MERS-CoV,ELISA,IgM,OD (450 nm),0.448,,0.32,13,Days,FALSE,,,
27109133,,Fig. 1A,Patient 1,,,China/South Korea,MERS-CoV,ELISA,IgM,OD (450 nm),0.592,,0.32,15,Days,FALSE,,,
27109133,,Fig. 1A,Patient 1,,,China/South Korea,MERS-CoV,ELISA,IgM,OD (450 nm),0.444,,0.32,18,Days,FALSE,,,
27109133,,Fig. 1A,Patient 1,,,China/South Korea,MERS-CoV,ELISA,IgM,OD (450 nm),0.376,,0.32,20,Days,FALSE,,,
27109133,,Fig. 1A,Patient 1,,,China/South Korea,MERS-CoV,ELISA,IgM,OD (450 nm),0.516,,0.32,27,Days,FALSE,,,
27109133,,Fig. 1A,Patient 1,,,China/South Korea,MERS-CoV,ELISA,IgM,OD (450 nm),0.636,,0.32,28,Days,FALSE,,,
27109133,,Fig. 1D,Patient 1,,,China/South Korea,MERS-CoV,NT,Neutralizing,Titre,141.4213562,,,6.214046823,Days,FALSE,,,
27109133,,Fig. 1D,Patient 1,,,China/South Korea,MERS-CoV,NT,Neutralizing,Titre,3466.444159,,,9.571906355,Days,FALSE,,,
27109133,,Fig. 1D,Patient 1,,,China/South Korea,MERS-CoV,NT,Neutralizing,Titre,4525.4834,,,10.56187291,Days,FALSE,,,
27109133,,Fig. 1D,Patient 1,,,China/South Korea,MERS-CoV,NT,Neutralizing,Titre,5310.475832,,,12.66889632,Days,FALSE,,,
27109133,,Fig. 1D,Patient 1,,,China/South Korea,MERS-CoV,NT,Neutralizing,Titre,5310.475832,,,13.71237458,Days,FALSE,,,
27109133,,Fig. 1D,Patient 1,,,China/South Korea,MERS-CoV,NT,Neutralizing,Titre,9546.652739,,,15.78595318,Days,FALSE,,,
27109133,,Fig. 1D,Patient 1,,,China/South Korea,MERS-CoV,NT,Neutralizing,Titre,3200,,,20.69230769,Days,FALSE,,,
27109133,,Fig. 1D,Patient 1,,,China/South Korea,MERS-CoV,NT,Neutralizing,Titre,3755.073472,,,27.49498328,Days,FALSE,,,
27109133,,Fig. 1D,Patient 1,,,China/South Korea,MERS-CoV,NT,Neutralizing,Titre,3755.073472,,,28.7993311,Days,FALSE,,,
28821364,,SM Table 3,Patient 4,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.345,,0.4,10,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 4,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.125,,0.2,10,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,Weakly positive,SM Table 3,Patient 4,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,10,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 4,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,10,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 4,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.337,,0.4,17,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 4,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.1,,0.2,17,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 4,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,17,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 4,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,17,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 4,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.262,,0.4,24,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 4,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.094,,0.2,24,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 4,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,24,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 4,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,24,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 4,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.283,,0.4,28,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 4,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.098,,0.2,28,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 4,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,28,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 4,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,28,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 5,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.316,,0.4,10,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 5,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.085,,0.2,10,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 5,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,10,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 5,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,10,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 5,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.582,,0.4,17,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 5,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.093,,0.2,17,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 5,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,17,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 5,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,17,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 5,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.372,,0.4,160,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 5,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.065,,0.2,160,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 5,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,,,160,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 5,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,160,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 6,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.055,,0.4,7,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 6,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.062,,0.2,7,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 6,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,7,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 6,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,7,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 6,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.097,,0.4,11,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 6,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.075,,0.2,11,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 6,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,11,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 6,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,11,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 7,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.106,,0.4,7,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 7,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.08,,0.2,7,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,Weakly positive,SM Table 3,Patient 7,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,7,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 7,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,7,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 8,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.075,,0.4,3,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 8,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.03,,0.2,3,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 8,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,3,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 8,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,3,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 8,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.316,,0.4,11,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 8,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.087,,0.2,11,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 8,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,11,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 8,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,11,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 8,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.267,,0.4,15,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 8,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.053,,0.2,15,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 8,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,15,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 8,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,15,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 8,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.302,,0.4,21,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 8,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.053,,0.2,21,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 8,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,21,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 8,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,21,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 9,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.05,,0.4,5,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 9,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.049,,0.2,5,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,1+ positive,SM Table 3,Patient 9,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,5,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 9,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,5,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 10,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.05,,0.4,7,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 10,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.06,,0.2,7,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 10,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,7,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 10,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,7,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 10,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.481,,0.4,14,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 10,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.097,,0.2,14,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 10,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,14,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 10,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,14,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 11,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.243,,0.4,17,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 11,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.409,,0.2,17,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 11,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,17,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 11,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,80,Positive,20,17,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 11,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.243,,0.4,94,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 11,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.409,,0.2,94,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,1+ positive,SM Table 3,Patient 11,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,94,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 11,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,40,Positive,,94,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 12,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.057,,0.4,9,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 12,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.059,,0.2,9,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 12,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,9,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 12,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,9,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 12,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.889,,0.4,16,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 12,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.143,,0.2,16,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,1+ positive,SM Table 3,Patient 12,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,16,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 12,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,20,Positive,,16,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 13,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.055,,0.4,11,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 13,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.086,,0.2,11,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 13,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,11,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 13,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,11,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 13,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.153,,0.4,18,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 13,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.884,,0.2,18,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,2+ positive,SM Table 3,Patient 13,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,18,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 13,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,80,Positive,,18,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 13,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.252,,0.4,21,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 13,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.832,,0.2,21,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,1+ positive,SM Table 3,Patient 13,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,21,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 13,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,40,Positive,,21,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 13,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,3.25,,0.4,151,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 13,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.161,,0.2,151,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 13,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,151,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 3,Patient 13,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,80,Positive,,151,Days,FALSE,,,Mild - no pneumonia - group 1
28821364,,SM Table 4,Patient 14,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.055,,0.4,14,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 14,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.068,,0.2,14,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 14,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,14,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 14,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,14,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 14,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.266,,0.4,156,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 14,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.117,,0.2,156,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 14,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,156,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 14,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,156,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 15,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.156,,0.4,12,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 15,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.155,,0.2,12,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,Weakly positive,SM Table 4,Patient 15,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,12,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 15,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,12,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 16,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.05,,0.4,4,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 16,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.055,,0.2,4,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,2+ positive,SM Table 4,Patient 16,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,4,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 16,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,4,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 16,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.05,,0.4,9,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 16,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.035,,0.2,9,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 16,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,9,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 16,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,9,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 16,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.085,,0.4,13,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 16,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.067,,0.2,13,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 16,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,13,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 16,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,13,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 17,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.062,,0.4,11,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 17,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.029,,0.2,11,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 17,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,11,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 17,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,11,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 17,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.032,,0.4,18,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 17,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.441,,0.2,18,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,2+ positive,SM Table 4,Patient 17,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,18,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 17,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,20,Positive,,18,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 17,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.587,,0.4,24,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 17,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,1.431,,0.2,24,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,2+ positive,SM Table 4,Patient 17,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,24,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 17,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,160,Positive,,24,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 17,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.394,,0.4,29,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 17,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,2.371,,0.2,29,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,2+ positive,SM Table 4,Patient 17,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,29,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 17,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,160,Positive,,29,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 18,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.051,,0.4,11,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 18,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.031,,0.2,11,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 18,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,11,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 18,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,11,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 18,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.35,,0.4,29,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 18,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,1.67,,0.2,29,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,4+ positive,SM Table 4,Patient 18,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,29,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 18,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,1280,Positive,,29,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 19,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.061,,0.4,8,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 19,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.073,,0.2,8,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,1+ positive,SM Table 4,Patient 19,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,8,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 19,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,8,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 19,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.372,,0.4,15,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 19,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.292,,0.2,15,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,2+ positive,SM Table 4,Patient 19,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,15,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 19,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,40,Positive,,15,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 19,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.636,,0.4,20,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 19,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,1.116,,0.2,20,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 19,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,20,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 19,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,320,Positive,,20,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 19,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,3.096,,0.4,152,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 19,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,1.366,,0.2,152,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,Weakly positive,SM Table 4,Patient 19,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,152,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 19,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,160,Positive,,152,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 20,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.05,,0.4,8,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 20,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.051,,0.2,8,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 20,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,8,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 20,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,8,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 20,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.485,,0.4,15,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 20,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.147,,0.2,15,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,2+ positive,SM Table 4,Patient 20,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,15,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 20,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,20,Positive,,15,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 20,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.311,,0.4,21,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 20,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,1.218,,0.2,21,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,2+ positive,SM Table 4,Patient 20,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,21,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 20,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,160,Positive,,21,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 21,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.107,,0.4,12,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 21,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.15,,0.2,12,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,Weakly positive,SM Table 4,Patient 21,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,12,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 21,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,12,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 21,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.066,,0.4,19,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 21,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,1.181,,0.2,19,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,3+ positive,SM Table 4,Patient 21,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,19,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 21,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,160,Positive,,19,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 21,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.168,,0.4,22,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 21,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,1.066,,0.2,22,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,3+ positive,SM Table 4,Patient 21,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,22,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 21,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,80,Positive,,22,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 22,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.065,,0.4,9,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 22,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.039,,0.2,9,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 22,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,9,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 22,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,9,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 22,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.349,,0.4,15,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 22,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.785,,0.2,15,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 22,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,15,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 22,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,40,Positive,,15,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 22,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.681,,0.4,23,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 22,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.603,,0.2,23,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 22,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,23,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 22,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,40,Positive,,23,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 23,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.054,,0.4,9,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 23,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.051,,0.2,9,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 23,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,9,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 23,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,9,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 23,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.647,,0.4,17,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 23,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.829,,0.2,17,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,2+ positive,SM Table 4,Patient 23,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,17,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 23,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,160,Positive,20,17,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 23,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.777,,0.4,155,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 23,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.648,,0.2,155,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,2+ positive,SM Table 4,Patient 23,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,,,155,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 23,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,160,Positive,20,155,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 24,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.378,,0.4,10,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 24,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.144,,0.2,10,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 24,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,10,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 24,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,10,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 24,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.77,,0.4,17,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 24,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.138,,0.2,17,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 24,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,17,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 24,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,20,Positive,20,17,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 24,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.922,,0.4,22,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 24,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.229,,0.2,22,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,Weakly positive,SM Table 4,Patient 24,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,22,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 24,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,40,Positive,20,22,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 24,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.247,,0.4,28,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 24,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.285,,0.2,28,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,Weakly positive,SM Table 4,Patient 24,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,28,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 24,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,20,Positive,20,28,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 24,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.447,,0.4,133,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 24,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.106,,0.2,133,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 24,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,133,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 24,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,40,Positive,20,133,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 25,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.065,,0.4,9,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 25,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.101,,0.2,9,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,Weakly positive,SM Table 4,Patient 25,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,9,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 25,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,9,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 25,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.927,,0.4,20,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 25,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,1.449,,0.2,20,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,1+ positive,SM Table 4,Patient 25,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,20,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 25,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,80,Positive,20,20,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 26,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.053,,0.4,7,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 26,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.103,,0.2,7,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 26,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,7,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 26,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,7,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 26,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.101,,0.4,14,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 26,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,1.346,,0.2,14,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,2+ positive,SM Table 4,Patient 26,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,14,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 26,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,80,Positive,20,14,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 27,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.06,,0.4,5,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 27,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.165,,0.2,5,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,Weakly positive,SM Table 4,Patient 27,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,5,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 27,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,5,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 27,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.221,,0.4,12,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 27,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.265,,0.2,12,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,3+ positive,SM Table 4,Patient 27,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,12,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 27,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,12,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 27,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.862,,0.4,20,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 27,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,1.008,,0.2,20,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,2+ positive,SM Table 4,Patient 27,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,20,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 27,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,40,Positive,20,20,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 28,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.077,,0.4,13,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 28,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.043,,0.2,13,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 28,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,13,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 28,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,13,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 28,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.331,,0.4,20,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 28,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.449,,0.2,20,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,4+ positive,SM Table 4,Patient 28,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,20,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 28,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,80,Positive,20,20,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 28,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.095,,0.4,25,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 28,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.702,,0.2,25,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,3+ positive,SM Table 4,Patient 28,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,25,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 28,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,160,Positive,20,25,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 28,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.186,,0.4,29,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 28,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.542,,0.2,29,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,3+ positive,SM Table 4,Patient 28,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,29,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 28,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,80,Positive,20,29,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 29,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.055,,0.4,10,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 29,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.043,,0.2,10,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 29,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,10,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 29,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,10,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 29,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.909,,0.4,20,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 29,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,1.673,,0.2,20,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,4+ positive,SM Table 4,Patient 29,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,20,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 29,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,320,Positive,20,20,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 29,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,3.583,,0.4,24,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 29,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,2.815,,0.2,24,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,2+ positive,SM Table 4,Patient 29,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,24,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 29,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,320,Positive,20,24,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 29,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,3.055,,0.4,30,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 29,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,2.324,,0.2,30,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,2+ positive,SM Table 4,Patient 29,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,30,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 29,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,160,Positive,20,30,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 30,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.067,,0.4,6,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 30,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.036,,0.2,6,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 30,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,6,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 30,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,6,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 30,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.51,,0.4,11,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 30,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.075,,0.2,11,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 30,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,11,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 30,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,11,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 30,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.867,,0.4,15,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 30,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.568,,0.2,15,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,1+ positive,SM Table 4,Patient 30,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,15,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 30,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,20,Positive,20,15,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 30,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.23,,0.4,147,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 30,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.171,,0.2,147,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 30,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,,,147,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 30,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,20,Positive,20,147,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 31,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.149,,0.4,3,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 31,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.07,,0.2,3,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 31,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,3,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 31,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,3,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 31,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.13,,0.4,5,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 31,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.047,,0.2,5,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 31,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,5,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 31,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,5,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 31,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.099,,0.4,9,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 31,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.045,,0.2,9,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 31,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,9,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 31,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,9,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 31,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.238,,0.4,79,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 31,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.3,,0.2,79,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,1+ positive,SM Table 4,Patient 31,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,79,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 31,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,20,Positive,20,79,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 31,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.54,,0.4,101,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 31,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.278,,0.2,101,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,1+ positive,SM Table 4,Patient 31,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,101,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 4,Patient 31,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,40,Positive,20,101,Days,FALSE,,,"Medium - pneumonia, no respiratory failure - group 2"
28821364,,SM Table 5,Patient 32,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.397,,0.4,10,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 32,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.103,,0.2,10,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,Weakly positive,SM Table 5,Patient 32,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,10,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 32,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,10,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 33,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.06,,0.4,14,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 33,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.035,,0.2,14,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 33,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,14,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 33,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,14,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 33,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.071,,0.4,21,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 33,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.022,,0.2,21,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 33,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,21,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 33,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,21,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 34,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.432,,0.4,142,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 34,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.131,,0.2,142,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 34,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,142,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 34,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,20,Positive,20,142,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 35,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.068,,0.4,12,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 35,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.059,,0.2,12,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 35,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,12,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 35,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,12,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 35,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.058,,0.4,19,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 35,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.061,,0.2,19,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 35,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,19,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 35,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,19,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 35,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.477,,0.4,24,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 35,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.199,,0.2,24,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,4+ positive,SM Table 5,Patient 35,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,24,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 35,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,80,Positive,20,24,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 35,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.862,,0.4,28,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 35,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,1.221,,0.2,28,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,1+ positive,SM Table 5,Patient 35,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,28,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 35,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,80,Positive,20,28,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 37,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.062,,0.4,13,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 37,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.1,,0.2,13,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,Weakly positive,SM Table 5,Patient 37,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,13,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 37,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,13,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 37,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.827,,0.4,21,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 37,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,1.56,,0.2,21,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,4+ positive,SM Table 5,Patient 37,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,21,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 37,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,80,Positive,20,21,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 37,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.277,,0.4,96,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 37,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.504,,0.2,96,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,1+ positive,SM Table 5,Patient 37,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,96,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 37,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,80,Positive,20,96,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 37,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.229,,0.4,173,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 37,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.245,,0.2,173,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 37,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,,,173,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 37,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,160,Positive,20,173,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 38,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.075,,0.4,11,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 38,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.083,,0.2,11,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 38,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,11,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 38,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,11,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 38,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.238,,0.4,18,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 38,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,1.17,,0.2,18,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,2+ positive,SM Table 5,Patient 38,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,18,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 38,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,160,Positive,20,18,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 40,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.064,,0.4,10,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 40,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.199,,0.2,10,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 40,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Negative,,10,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 40,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,10,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 40,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.537,,0.4,17,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 40,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.688,,0.2,17,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,1+ positive,SM Table 5,Patient 40,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,17,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 40,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,40,Positive,20,17,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 40,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.352,,0.4,25,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 40,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,2.072,,0.2,25,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,2+ positive,SM Table 5,Patient 40,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,25,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 40,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,80,Positive,20,25,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 40,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.804,,0.4,93,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 40,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.916,,0.2,93,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,2+ positive,SM Table 5,Patient 40,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,93,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 40,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,160,Positive,20,93,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 41,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.082,,0.4,16,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 41,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,0.106,,0.2,16,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,Weakly positive,SM Table 5,Patient 41,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,16,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 41,,,South Korea,MERS-CoV,PRNT,Neutralizing,Seropositive,,Negative,,16,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 41,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.031,,0.4,23,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 41,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,1.883,,0.2,23,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,4+ positive,SM Table 5,Patient 41,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,23,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 41,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,160,Positive,20,23,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 41,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.738,,0.4,28,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 41,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,2.811,,0.2,28,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,3+ positive,SM Table 5,Patient 41,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,28,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 41,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,160,Positive,20,28,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 41,,,South Korea,MERS-CoV,ELISA,IgG,OD ratio,3.441,,0.4,35,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 41,,,South Korea,MERS-CoV,ELISA,IgA,OD ratio,2.816,,0.2,35,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,3+ positive,SM Table 5,Patient 41,,,South Korea,MERS-CoV,IFA,IgM,Seropositive,,Positive,,35,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
28821364,,SM Table 5,Patient 41,,,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,320,Positive,,35,Days,FALSE,,,Severe - pneumonia and respiratory failure - group 3
27192543,,Table,Patient 1,49,M,Saudi Arabia,MERS-CoV,ELISA,,OD,3.17,,0.8,3,Months,FALSE,,,Severe pneumonia
27192543,,Table,Patient 1,49,M,Saudi Arabia,MERS-CoV,ELISA,,OD,2.99,,0.8,10,Months,FALSE,,,Severe pneumonia
27192543,,Table,Patient 1,49,M,Saudi Arabia,MERS-CoV,ELISA,,OD,3.3,,0.8,18,Months,FALSE,,,Severe pneumonia
27192543,,Table,Patient 1,49,M,Saudi Arabia,MERS-CoV,IFA,IgG,Seropositive,,Positive,,3,Months,FALSE,,,Severe pneumonia
27192543,,Table,Patient 1,49,M,Saudi Arabia,MERS-CoV,IFA,IgG,Seropositive,,Positive,,10,Months,FALSE,,,Severe pneumonia
27192543,,Table,Patient 1,49,M,Saudi Arabia,MERS-CoV,IFA,IgG,Seropositive,,Positive,,18,Months,FALSE,,,Severe pneumonia
27192543,,Table,Patient 2,33,F,Saudi Arabia,MERS-CoV,ELISA,,OD,2.7,,0.8,3,Months,FALSE,,,Severe pneumonia
27192543,,Table,Patient 2,33,F,Saudi Arabia,MERS-CoV,ELISA,,OD,2.09,,0.8,10,Months,FALSE,,,Severe pneumonia
27192543,,Table,Patient 2,33,F,Saudi Arabia,MERS-CoV,ELISA,,OD,2.9,,0.8,18,Months,FALSE,,,Severe pneumonia
27192543,,Table,Patient 2,33,F,Saudi Arabia,MERS-CoV,IFA,IgG,Seropositive,,Positive,,3,Months,FALSE,,,Severe pneumonia
27192543,,Table,Patient 2,33,F,Saudi Arabia,MERS-CoV,IFA,IgG,Seropositive,,Positive,,10,Months,FALSE,,,Severe pneumonia
27192543,,Table,Patient 2,33,F,Saudi Arabia,MERS-CoV,IFA,IgG,Seropositive,,Positive,,18,Months,FALSE,,,Severe pneumonia
27192543,,Table,Patient 3,54,F,Saudi Arabia,MERS-CoV,ELISA,,OD,2.91,,0.8,3,Months,FALSE,,,Pneumonia
27192543,,Table,Patient 3,54,F,Saudi Arabia,MERS-CoV,ELISA,,OD,1.9,,0.8,10,Months,FALSE,,,Pneumonia
27192543,,Table,Patient 3,54,F,Saudi Arabia,MERS-CoV,IFA,IgG,Seropositive,,Positive,,3,Months,FALSE,,,Pneumonia
27192543,,Table,Patient 3,54,F,Saudi Arabia,MERS-CoV,IFA,IgG,Seropositive,,Positive,,10,Months,FALSE,,,Pneumonia
27192543,,Table,Patient 4,40,M,Saudi Arabia,MERS-CoV,ELISA,,OD,1.29,,0.8,3,Months,FALSE,,,Pneumonia
27192543,,Table,Patient 4,40,M,Saudi Arabia,MERS-CoV,ELISA,,OD,0.65,,0.8,10,Months,FALSE,,,Pneumonia
27192543,,Table,Patient 4,40,M,Saudi Arabia,MERS-CoV,IFA,IgG,Seropositive,,Positive,,3,Months,FALSE,,,Pneumonia
27192543,,Table,Patient 4,40,M,Saudi Arabia,MERS-CoV,IFA,IgG,Seropositive,,Negative,,10,Months,FALSE,,,Pneumonia
27192543,,Table,Patient 5,37,M,Saudi Arabia,MERS-CoV,ELISA,,OD,3.2,,0.8,3,Months,FALSE,,,Pneumonia
27192543,,Table,Patient 5,37,M,Saudi Arabia,MERS-CoV,ELISA,,OD,1.2,,0.8,10,Months,FALSE,,,Pneumonia
27192543,,Table,Patient 5,37,M,Saudi Arabia,MERS-CoV,IFA,IgG,Seropositive,,Positive,,3,Months,FALSE,,,Pneumonia
27192543,,Table,Patient 5,37,M,Saudi Arabia,MERS-CoV,IFA,IgG,Seropositive,,Negative,,10,Months,FALSE,,,Pneumonia
27192543,,Table,Patient 6,36,M,Saudi Arabia,MERS-CoV,ELISA,,OD,0.07,,0.8,3,Months,FALSE,,,Upper respiratory tract infection
27192543,,Table,Patient 6,36,M,Saudi Arabia,MERS-CoV,ELISA,,OD,0.07,,0.8,10,Months,FALSE,,,Upper respiratory tract infection
27192543,,Table,Patient 6,36,M,Saudi Arabia,MERS-CoV,IFA,IgG,Seropositive,,Negative,,3,Months,FALSE,,,Upper respiratory tract infection
27192543,,Table,Patient 6,36,M,Saudi Arabia,MERS-CoV,IFA,IgG,Seropositive,,Negative,,10,Months,FALSE,,,Upper respiratory tract infection
27192543,,Table,Patient 7,27,F,Saudi Arabia,MERS-CoV,ELISA,,OD,0.046,,0.8,3,Months,FALSE,,,Asymptomatic
27192543,,Table,Patient 7,27,F,Saudi Arabia,MERS-CoV,ELISA,,OD,0.04,,0.8,10,Months,FALSE,,,Asymptomatic
27192543,,Table,Patient 7,27,F,Saudi Arabia,MERS-CoV,IFA,IgG,Seropositive,,Negative,,3,Months,FALSE,,,Asymptomatic
27192543,,Table,Patient 7,27,F,Saudi Arabia,MERS-CoV,IFA,IgG,Seropositive,,Negative,,10,Months,FALSE,,,Asymptomatic
27192543,,Table,Patient 8,28,F,Saudi Arabia,MERS-CoV,ELISA,,OD,0.12,,0.8,3,Months,FALSE,,,Asymptomatic
27192543,,Table,Patient 8,28,F,Saudi Arabia,MERS-CoV,ELISA,,OD,0.06,,0.8,10,Months,FALSE,,,Asymptomatic
27192543,,Table,Patient 8,28,F,Saudi Arabia,MERS-CoV,IFA,IgG,Seropositive,,Negative,,3,Months,FALSE,,,Asymptomatic
27192543,,Table,Patient 8,28,F,Saudi Arabia,MERS-CoV,IFA,IgG,Seropositive,,Negative,,10,Months,FALSE,,,Asymptomatic
27192543,,Table,Patient 9,35,M,Saudi Arabia,MERS-CoV,ELISA,,OD,0.07,,0.8,3,Months,FALSE,,,Asymptomatic
27192543,,Table,Patient 9,35,M,Saudi Arabia,MERS-CoV,ELISA,,OD,0.04,,0.8,10,Months,FALSE,,,Asymptomatic
27192543,,Table,Patient 9,35,M,Saudi Arabia,MERS-CoV,IFA,IgG,Seropositive,,Negative,,3,Months,FALSE,,,Asymptomatic
27192543,,Table,Patient 9,35,M,Saudi Arabia,MERS-CoV,IFA,IgG,Seropositive,,Negative,,10,Months,FALSE,,,Asymptomatic
28585916,,Figure A,Patient C,55,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,10,,10,1,Days,FALSE,,,Severe
28585916,,Figure A,Patient C,55,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,40,,10,4,Days,FALSE,,,Severe
28585916,,Figure A,Patient C,55,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,160,,10,8,Days,FALSE,,,Severe
28585916,,Figure A,Patient C,55,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,640,,10,11,Days,FALSE,,,Severe
28585916,,Figure A,Patient C,55,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,640,,10,16,Days,FALSE,,,Severe
28585916,,Figure A,Patient C,55,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,640,,10,19,Days,FALSE,,,Severe
28585916,,Figure A,Patient C,55,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,160,,10,209,Days,FALSE,,,Severe
28585916,,Figure A,Patient C,55,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,80,,10,338,Days,FALSE,,,Severe
28585916,,Figure A,Patient D,35,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,160,,10,15,Days,FALSE,,,Severe
28585916,,Figure A,Patient D,35,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,160,,10,18,Days,FALSE,,,Severe
28585916,,Figure A,Patient D,35,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,160,,10,21,Days,FALSE,,,Severe
28585916,,Figure A,Patient D,35,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,320,,10,24,Days,FALSE,,,Severe
28585916,,Figure A,Patient D,35,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,160,,10,31,Days,FALSE,,,Severe
28585916,,Figure A,Patient D,35,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,160,,10,57,Days,FALSE,,,Severe
28585916,,Figure A,Patient D,35,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,80,,10,183,Days,FALSE,,,Severe
28585916,,Figure A,Patient D,35,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,80,,10,296,Days,FALSE,,,Severe
28585916,,Figure A,Patient D,35,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,80,,10,400,Days,FALSE,,,Severe
28585916,,Figure A,Patient F,55,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,40,,10,8,Days,FALSE,,,Severe
28585916,,Figure A,Patient F,55,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,80,,10,10,Days,FALSE,,,Severe
28585916,,Figure A,Patient F,55,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,320,,10,14,Days,FALSE,,,Severe
28585916,,Figure A,Patient F,55,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,320,,10,17,Days,FALSE,,,Severe
28585916,,Figure A,Patient F,55,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,320,,10,24,Days,FALSE,,,Severe
28585916,,Figure A,Patient F,55,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,160,,10,52,Days,FALSE,,,Severe
28585916,,Figure A,Patient F,55,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,80,,10,242,Days,FALSE,,,Severe
28585916,,Figure A,Patient F,55,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,80,,10,311,Days,FALSE,,,Severe
28585916,,Figure A,Patient F,55,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,80,,10,397,Days,FALSE,,,Severe
28585916,,Figure A,Patient G,56,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,<=10,,10,2,Days,FALSE,,,Severe
28585916,,Figure A,Patient G,56,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,<=10,,10,7,Days,FALSE,,,Severe
28585916,,Figure A,Patient G,56,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,20,,10,11,Days,FALSE,,,Severe
28585916,,Figure A,Patient G,56,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,40,,10,14,Days,FALSE,,,Severe
28585916,,Figure A,Patient G,56,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,80,,10,18,Days,FALSE,,,Severe
28585916,,Figure A,Patient G,56,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,80,,10,21,Days,FALSE,,,Severe
28585916,,Figure A,Patient G,56,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,80,,10,25,Days,FALSE,,,Severe
28585916,,Figure A,Patient G,56,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,80,,10,28,Days,FALSE,,,Severe
28585916,,Figure A,Patient G,56,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,80,,10,31,Days,FALSE,,,Severe
28585916,,Figure A,Patient G,56,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,80,,10,216,Days,FALSE,,,Severe
28585916,,Figure A,Patient G,56,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,80,,10,355,Days,FALSE,,,Severe
28585916,,Figure A,Patient I,77,F,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,<=10,,10,19,Days,FALSE,,,Severe
28585916,,Figure A,Patient I,77,F,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,<=10,,10,22,Days,FALSE,,,Severe
28585916,,Figure A,Patient I,77,F,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,40,,10,25,Days,FALSE,,,Severe
28585916,,Figure A,Patient I,77,F,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,80,,10,187,Days,FALSE,,,Severe
28585916,,Figure A,Patient I,77,F,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,80,,10,295,Days,FALSE,,,Severe
28585916,,Figure A,Patient I,77,F,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,40,,10,377,Days,FALSE,,,Severe
28585916,These points not really visible from plot. May be more than one in close proximity.,Figure A,Patient K,59,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,<=10,,10,19,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient K,59,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,80,,10,23,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient K,59,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,80,,10,28,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient K,59,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,40,,10,420,Days,FALSE,,,Non-severe
28585916,These points not really visible from plot. May be more than one in close proximity.,Figure A,Patient L,56,F,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,<=10,,10,5,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient L,56,F,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,<=10,,10,12,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient L,56,F,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,<=10,,10,16,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient L,56,F,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,<=10,,10,32,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient L,56,F,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,<=10,,10,99,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient L,56,F,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,10,,10,192,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient L,56,F,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,10,,10,285,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient L,56,F,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,10,,10,403,Days,FALSE,,,Non-severe
28585916,These points not really visible from plot. May be more than one in close proximity.,Figure A,Patient M,56,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,<=10,,10,4,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient M,56,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,<=10,,10,9,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient M,56,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,<=10,,10,13,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient M,56,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,<=10,,10,16,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient M,56,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,<=10,,10,209,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient M,56,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,<=10,,10,296,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient M,56,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,<=10,,10,394,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient N,54,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,<=10,,10,16,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient N,54,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,<=10,,10,21,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient N,54,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,20,,10,25,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient N,54,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,20,,10,28,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient N,54,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,40,,10,32,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient N,54,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,80,,10,47,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient N,54,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,40,,10,232,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient N,54,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,40,,10,308,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient N,54,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,40,,10,406,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient O,46,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,<=10,,10,9,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient O,46,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,10,,10,218,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient O,46,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,10,,10,294,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient O,46,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,10,,10,379,Days,FALSE,,,Non-severe
28585916,These points not really visible from plot. May be more than one in close proximity.,Figure A,Patient P,35,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,<=10,,10,7,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient P,35,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,10,,10,49,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient P,35,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,<=10,,10,212,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient P,35,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,<=10,,10,291,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient P,35,M,South Korea,MERS-CoV,PRNT,Neutralizing,Titre,<=10,,10,386,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient C,55,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.603448276,,0.8,9,Days,FALSE,,,Severe
28585916,,Figure A,Patient C,55,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.896551724,,0.8,12,Days,FALSE,,,Severe
28585916,,Figure A,Patient C,55,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,4.293103448,,0.8,15,Days,FALSE,,,Severe
28585916,,Figure A,Patient C,55,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,5,,0.8,19,Days,FALSE,,,Severe
28585916,,Figure A,Patient C,55,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,5.603448276,,0.8,23,Days,FALSE,,,Severe
28585916,,Figure A,Patient C,55,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,6.689655172,,0.8,26,Days,FALSE,,,Severe
28585916,,Figure A,Patient C,55,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,3.103448276,,0.8,216,Days,FALSE,,,Severe
28585916,,Figure A,Patient C,55,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.706896552,,0.8,332,Days,FALSE,,,Severe
28585916,,Figure A,Patient D,35,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2,,0.8,16,Days,FALSE,,,Severe
28585916,,Figure A,Patient D,35,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.896551724,,0.8,18,Days,FALSE,,,Severe
28585916,,Figure A,Patient D,35,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,3.189655172,,0.8,22,Days,FALSE,,,Severe
28585916,,Figure A,Patient D,35,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,3.103448276,,0.8,25,Days,FALSE,,,Severe
28585916,,Figure A,Patient D,35,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,3.189655172,,0.8,32,Days,FALSE,,,Severe
28585916,,Figure A,Patient D,35,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,3.982758621,,0.8,58,Days,FALSE,,,Severe
28585916,,Figure A,Patient D,35,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,3.603448276,,0.8,184,Days,FALSE,,,Severe
28585916,,Figure A,Patient D,35,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,3.603448276,,0.8,297,Days,FALSE,,,Severe
28585916,,Figure A,Patient D,35,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,3,,0.8,400,Days,FALSE,,,Severe
28585916,,Figure A,Patient F,55,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.879310345,,0.8,19,Days,FALSE,,,Severe
28585916,,Figure A,Patient F,55,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.775862069,,0.8,22,Days,FALSE,,,Severe
28585916,,Figure A,Patient F,55,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,3.879310345,,0.8,25,Days,FALSE,,,Severe
28585916,,Figure A,Patient F,55,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,3.879310345,,0.8,28,Days,FALSE,,,Severe
28585916,,Figure A,Patient F,55,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,4.086206897,,0.8,35,Days,FALSE,,,Severe
28585916,,Figure A,Patient F,55,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,3.879310345,,0.8,63,Days,FALSE,,,Severe
28585916,,Figure A,Patient F,55,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.189655172,,0.8,253,Days,FALSE,,,Severe
28585916,,Figure A,Patient F,55,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2,,0.8,317,Days,FALSE,,,Severe
28585916,,Figure A,Patient F,55,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.172413793,,0.8,408,Days,FALSE,,,Severe
28585916,,Figure A,Patient G,56,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.5,,0.8,10,Days,FALSE,,,Severe
28585916,,Figure A,Patient G,56,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.5,,0.8,15,Days,FALSE,,,Severe
28585916,,Figure A,Patient G,56,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.396551724,,0.8,19,Days,FALSE,,,Severe
28585916,,Figure A,Patient G,56,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.482758621,,0.8,22,Days,FALSE,,,Severe
28585916,,Figure A,Patient G,56,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.896551724,,0.8,26,Days,FALSE,,,Severe
28585916,,Figure A,Patient G,56,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,3.396551724,,0.8,29,Days,FALSE,,,Severe
28585916,,Figure A,Patient G,56,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,3.706896552,,0.8,33,Days,FALSE,,,Severe
28585916,,Figure A,Patient G,56,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,3.896551724,,0.8,36,Days,FALSE,,,Severe
28585916,,Figure A,Patient G,56,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,3.793103448,,0.8,40,Days,FALSE,,,Severe
28585916,,Figure A,Patient G,56,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,3.396551724,,0.8,224,Days,FALSE,,,Severe
28585916,,Figure A,Patient G,56,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,3,,0.8,363,Days,FALSE,,,Severe
28585916,,Figure A,Patient I,77,F,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.5,,0.8,17,Days,FALSE,,,Severe
28585916,,Figure A,Patient I,77,F,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.5,,0.8,20,Days,FALSE,,,Severe
28585916,,Figure A,Patient I,77,F,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.620689655,,0.8,23,Days,FALSE,,,Severe
28585916,,Figure A,Patient I,77,F,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.913793103,,0.8,185,Days,FALSE,,,Severe
28585916,,Figure A,Patient I,77,F,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.603448276,,0.8,303,Days,FALSE,,,Severe
28585916,,Figure A,Patient I,77,F,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.103448276,,0.8,375,Days,FALSE,,,Severe
28585916,,Figure A,Patient K,59,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.482758621,,0.8,17,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient K,59,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.5,,0.8,22,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient K,59,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.189655172,,0.8,27,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient K,59,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.603448276,,0.8,425,Days,FALSE,,,Non-severe
28585916,These points not really visible from plot. May be more than one in close proximity.,Figure A,Patient L,56,F,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.862068966,,0.8,21,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient L,56,F,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.482758621,,0.8,37,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient L,56,F,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.896551724,,0.8,104,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient L,56,F,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.793103448,,0.8,197,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient L,56,F,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.896551724,,0.8,290,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient L,56,F,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.896551724,,0.8,408,Days,FALSE,,,Non-severe
28585916,These points not really visible from plot. May be more than one in close proximity.,Figure A,Patient M,56,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.5,,0.8,21,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient M,56,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.603448276,,0.8,214,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient M,56,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.603448276,,0.8,301,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient M,56,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.603448276,,0.8,399,Days,FALSE,,,Non-severe
28585916,These points not really visible from plot. May be more than one in close proximity.,Figure A,Patient N,54,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.5,,0.8,5,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient N,54,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.5,,0.8,11,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient N,54,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.689655172,,0.8,15,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient N,54,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,3.293103448,,0.8,18,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient N,54,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,3.603448276,,0.8,19,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient N,54,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,4.586206897,,0.8,29,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient N,54,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.103448276,,0.8,222,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient N,54,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.103448276,,0.8,298,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient N,54,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.896551724,,0.8,396,Days,FALSE,,,Non-severe
28585916,These points not really visible from plot. May be more than one in close proximity.,Figure A,Patient O,46,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.5,,0.8,14,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient O,46,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.103448276,,0.8,223,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient O,46,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1,,0.8,299,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient O,46,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1,,0.8,384,Days,FALSE,,,Non-severe
28585916,These points not really visible from plot. May be more than one in close proximity.,Figure A,Patient P,35,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.5,,0.8,11,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient P,35,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1,,0.8,14,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient P,35,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.793103448,,0.8,54,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient P,35,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.689655172,,0.8,217,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient P,35,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.689655172,,0.8,295,Days,FALSE,,,Non-severe
28585916,,Figure A,Patient P,35,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.689655172,,0.8,391,Days,FALSE,,,Non-severe
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,Ab,Cumulative proportion,,,,0,Days,TRUE,0,141,Non-critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,Ab,Cumulative proportion,,,,1,Days,TRUE,1,141,Non-critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,Ab,Cumulative proportion,,,,2,Days,TRUE,3,141,Non-critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,Ab,Cumulative proportion,,,,3,Days,TRUE,4,141,Non-critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,Ab,Cumulative proportion,,,,4,Days,TRUE,7,141,Non-critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,Ab,Cumulative proportion,,,,5,Days,TRUE,11,141,Non-critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,Ab,Cumulative proportion,,,,6,Days,TRUE,23,141,Non-critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,Ab,Cumulative proportion,,,,7,Days,TRUE,31,141,Non-critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,Ab,Cumulative proportion,,,,8,Days,TRUE,47,141,Non-critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,Ab,Cumulative proportion,,,,9,Days,TRUE,56,141,Non-critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,Ab,Cumulative proportion,,,,10,Days,TRUE,67,141,Non-critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,Ab,Cumulative proportion,,,,11,Days,TRUE,82,141,Non-critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,Ab,Cumulative proportion,,,,12,Days,TRUE,99,141,Non-critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,Ab,Cumulative proportion,,,,13,Days,TRUE,110,141,Non-critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,Ab,Cumulative proportion,,,,14,Days,TRUE,117,141,Non-critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,Ab,Cumulative proportion,,,,15,Days,TRUE,123,141,Non-critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,Ab,Cumulative proportion,,,,16,Days,TRUE,128,141,Non-critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,Ab,Cumulative proportion,,,,17,Days,TRUE,131,141,Non-critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,Ab,Cumulative proportion,,,,18,Days,TRUE,134,141,Non-critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,Ab,Cumulative proportion,,,,19,Days,TRUE,137,141,Non-critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,Ab,Cumulative proportion,,,,20,Days,TRUE,137,141,Non-critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,Ab,Cumulative proportion,,,,21,Days,TRUE,137,141,Non-critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,Ab,Cumulative proportion,,,,22,Days,TRUE,138,141,Non-critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,Ab,Cumulative proportion,,,,24,Days,TRUE,139,141,Non-critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,Ab,Cumulative proportion,,,,39,Days,TRUE,140,141,Non-critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,Ab,Cumulative proportion,,,,0,Days,TRUE,0,32,Critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,Ab,Cumulative proportion,,,,4,Days,TRUE,2,32,Critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,Ab,Cumulative proportion,,,,5,Days,TRUE,3,32,Critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,Ab,Cumulative proportion,,,,6,Days,TRUE,5,32,Critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,Ab,Cumulative proportion,,,,8,Days,TRUE,6,32,Critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,Ab,Cumulative proportion,,,,9,Days,TRUE,9,32,Critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,Ab,Cumulative proportion,,,,10,Days,TRUE,11,32,Critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,Ab,Cumulative proportion,,,,11,Days,TRUE,14,32,Critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,Ab,Cumulative proportion,,,,12,Days,TRUE,19,32,Critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,Ab,Cumulative proportion,,,,13,Days,TRUE,20,32,Critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,Ab,Cumulative proportion,,,,14,Days,TRUE,21,32,Critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,Ab,Cumulative proportion,,,,15,Days,TRUE,24,32,Critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,Ab,Cumulative proportion,,,,17,Days,TRUE,26,32,Critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,Ab,Cumulative proportion,,,,18,Days,TRUE,28,32,Critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,Ab,Cumulative proportion,,,,19,Days,TRUE,29,32,Critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,20,Days,TRUE,31,32,Critical
Zhao et al. preprint,,Figure 1B,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,21,Days,TRUE,32,32,Critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,0,Days,TRUE,0,141,Non-critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,1,Days,TRUE,1,141,Non-critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,2,Days,TRUE,3,141,Non-critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,3,Days,TRUE,4,141,Non-critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,4,Days,TRUE,5,141,Non-critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,5,Days,TRUE,9,141,Non-critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,6,Days,TRUE,17,141,Non-critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,7,Days,TRUE,23,141,Non-critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,8,Days,TRUE,35,141,Non-critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,9,Days,TRUE,41,141,Non-critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,10,Days,TRUE,52,141,Non-critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,11,Days,TRUE,69,141,Non-critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,12,Days,TRUE,85,141,Non-critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,13,Days,TRUE,96,141,Non-critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,14,Days,TRUE,102,141,Non-critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,15,Days,TRUE,108,141,Non-critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,16,Days,TRUE,114,141,Non-critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,17,Days,TRUE,122,141,Non-critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,18,Days,TRUE,129,141,Non-critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,19,Days,TRUE,132,141,Non-critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,20,Days,TRUE,134,141,Non-critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,21,Days,TRUE,136,141,Non-critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,22,Days,TRUE,138,141,Non-critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,27,Days,TRUE,140,141,Non-critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,39,Days,TRUE,142,141,Non-critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,0,Days,TRUE,0,32,Critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,4,Days,TRUE,1,32,Critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,5,Days,TRUE,2,32,Critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,6,Days,TRUE,3,32,Critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,7,Days,TRUE,4,32,Critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,8,Days,TRUE,5,32,Critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,9,Days,TRUE,7,32,Critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,10,Days,TRUE,8,32,Critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,11,Days,TRUE,10,32,Critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,12,Days,TRUE,17,32,Critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,13,Days,TRUE,19,32,Critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,14,Days,TRUE,20,32,Critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,15,Days,TRUE,22,32,Critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,16,Days,TRUE,23,32,Critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,17,Days,TRUE,24,32,Critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,18,Days,TRUE,25,32,Critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,19,Days,TRUE,28,32,Critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,20,Days,TRUE,30,32,Critical
Zhao et al. preprint,,Figure 1C,,,,China,SARS-CoV-2,ELISA,IgM,Cumulative proportion,,,,25,Days,TRUE,32,32,Critical
Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proportion,,,,0,Days,TRUE,0,141,Non-critical
Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proportion,,,,1,Days,TRUE,1,141,Non-critical
Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proportion,,,,2,Days,TRUE,2,141,Non-critical
Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proportion,,,,3,Days,TRUE,3,141,Non-critical
Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proportion,,,,5,Days,TRUE,6,141,Non-critical
Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proportion,,,,6,Days,TRUE,11,141,Non-critical
Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proportion,,,,7,Days,TRUE,15,141,Non-critical
Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proportion,,,,8,Days,TRUE,22,141,Non-critical
Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proportion,,,,9,Days,TRUE,28,141,Non-critical
Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proportion,,,,10,Days,TRUE,39,141,Non-critical
Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proportion,,,,11,Days,TRUE,50,141,Non-critical
Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proportion,,,,12,Days,TRUE,66,141,Non-critical
Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proportion,,,,13,Days,TRUE,75,141,Non-critical
Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proportion,,,,14,Days,TRUE,80,141,Non-critical
Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proportion,,,,15,Days,TRUE,89,141,Non-critical
Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proportion,,,,16,Days,TRUE,102,141,Non-critical
Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proportion,,,,17,Days,TRUE,112,141,Non-critical
Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proportion,,,,18,Days,TRUE,121,141,Non-critical
Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proportion,,,,19,Days,TRUE,124,141,Non-critical
Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proportion,,,,20,Days,TRUE,127,141,Non-critical
Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proportion,,,,39,Days,TRUE,127,141,Non-critical
Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proportion,,,,0,Days,TRUE,0,32,Critical
Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proportion,,,,5,Days,TRUE,1,32,Critical
Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proportion,,,,6,Days,TRUE,3,32,Critical
Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proportion,,,,8,Days,TRUE,5,32,Critical
Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proportion,,,,9,Days,TRUE,6,32,Critical
Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proportion,,,,10,Days,TRUE,8,32,Critical
Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proportion,,,,11,Days,TRUE,9,32,Critical
Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proportion,,,,12,Days,TRUE,12,32,Critical
Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proportion,,,,14,Days,TRUE,15,32,Critical
Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proportion,,,,15,Days,TRUE,17,32,Critical
Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proportion,,,,17,Days,TRUE,18,32,Critical
Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proportion,,,,18,Days,TRUE,20,32,Critical
Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proportion,,,,19,Days,TRUE,22,32,Critical
Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proportion,,,,20,Days,TRUE,24,32,Critical
Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proportion,,,,22,Days,TRUE,26,32,Critical
Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proportion,,,,23,Days,TRUE,27,32,Critical
Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proportion,,,,25,Days,TRUE,29,32,Critical
Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proportion,,,,27,Days,TRUE,30,32,Critical
Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proportion,,,,28,Days,TRUE,32,32,Critical
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,A,38,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,<10,,10,2,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,A,38,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,<10,,10,6,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,A,38,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,<10,,10,9,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,A,38,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,<10,,10,11,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,A,38,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,<10,,10,13,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,A,38,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,<10,,10,15,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,A,38,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,10,,10,18,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,A,38,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,160,,10,21,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,B,65,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,<10,,10,12,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,B,65,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,20,,10,13,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,B,65,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,>=320,,10,18,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,B,65,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,>=320,,10,21,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,B,65,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,>=320,,10,25,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,B,65,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,>=320,,10,32,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,B,65,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,>=320,,10,35,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,B,65,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,>=320,,10,39,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,C,55,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,40,,10,9,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,C,55,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,160,,10,12,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,C,55,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,>=320,,10,16,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,C,55,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,>=320,,10,19,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,C,55,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,>=320,,10,23,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,C,55,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,>=320,,10,26,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,D,35,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,>=320,,10,13,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,D,35,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,>=320,,10,16,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,D,35,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,>=320,,10,18,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,D,35,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,>=320,,10,22,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,D,35,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,>=320,,10,25,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,D,35,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,>=320,,10,29,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,E,79,F,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,<10,,10,2,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,E,79,F,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,<10,,10,9,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,E,79,F,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,<10,,10,6,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,E,79,F,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,<10,,10,11,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,E,79,F,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,<10,,10,13,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,E,79,F,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,10,,10,16,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,F,55,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,160,,10,14,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,F,55,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,>=320,,10,17,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,F,55,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,>=320,,10,20,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,F,55,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,>=320,,10,23,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,F,55,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,>=320,,10,28,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,F,55,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,>=320,,10,30,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,G,56,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,<10,,10,5,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,G,56,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,<10,,10,10,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,G,56,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,80,,10,14,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,G,56,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,160,,10,17,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,G,56,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,>=320,,10,24,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,G,56,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,>=320,,10,28,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,G,56,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,>=320,,10,31,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,G,56,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,>=320,,10,35,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,H,71,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,<10,,10,8,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,H,71,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,10,,10,10,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,H,71,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,20,,10,17,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,H,71,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,>=320,,10,21,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,H,71,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,>=320,,10,24,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,H,71,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,>=320,,10,28,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,H,71,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,>=320,,10,31,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,I,77,F,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,<10,,10,12,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,I,77,F,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,<10,,10,15,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,I,77,F,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,160,,10,18,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,J,76,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,<10,,10,4,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,J,76,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,10,,10,9,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,J,76,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,80,,10,13,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,J,76,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,80,,10,16,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,J,76,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,160,,10,20,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,J,76,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,>=320,,10,27,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,K,59,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,<10,,10,10,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,K,59,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,10,,10,13,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,K,59,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,>=320,,10,17,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,L,56,F,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,10,,10,12,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,L,56,F,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,10,,10,16,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,L,56,F,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,20,,10,32,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,M,56,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,<10,,10,4,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,M,56,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,<10,,10,9,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,M,56,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,10,,10,13,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,M,56,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,10,,10,17,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,N,54,F,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,<10,,10,4,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,N,54,F,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,10,,10,9,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,N,54,F,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,80,,10,13,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,N,54,F,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,80,,10,16,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,N,54,F,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,160,,10,20,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,N,54,F,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,>=320,,10,27,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,O,46,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,<10,,10,6,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,O,46,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,10,,10,8,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,P,35,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,10,,10,5,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,P,35,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,10,,10,6,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,P,35,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,10,,10,8,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,P,35,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,10,,10,9,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,Q,52,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,<10,,10,7,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,Q,52,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,10,,10,10,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,Q,52,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,20,,10,14,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,Q,52,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,160,,10,17,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,Q,52,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,>=320,,10,21,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure B,Q,52,M,South Korea,MERS-CoV,PRNT (50),Neutralizing,Titre,>=320,,10,25,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,A,38,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.069767442,,0.8,2,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,A,38,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.11627907,,0.8,4,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,A,38,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.11627907,,0.8,5,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,A,38,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.11627907,,0.8,6,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,A,38,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.162790698,,0.8,8,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,A,38,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.302325581,,0.8,9,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,A,38,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.069767442,,0.8,11,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,A,38,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.11627907,,0.8,13,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,A,38,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.11627907,,0.8,15,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,A,38,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.186046512,,0.8,18,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,A,38,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.093023256,,0.8,21,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,B,65,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.11627907,,0.8,13,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,B,65,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.488372093,,0.8,18,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,B,65,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.186046512,,0.8,21,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,B,65,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.186046512,,0.8,25,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,B,65,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.790697674,,0.8,28,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,B,65,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.76744186,,0.8,32,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,B,65,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.488372093,,0.8,35,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,B,65,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.11627907,,0.8,39,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,C,55,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.162790698,,0.8,9,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,C,55,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.395348837,,0.8,12,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,C,55,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,3.790697674,,0.8,16,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,C,55,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,4.488372093,,0.8,19,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,C,55,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,5.139534884,,0.8,23,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,C,55,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,6.209302326,,0.8,26,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,D,35,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.488372093,,0.8,13,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,D,35,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.395348837,,0.8,16,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,D,35,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.581395349,,0.8,19,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,D,35,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.488372093,,0.8,22,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,D,35,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.581395349,,0.8,29,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,E,79,F,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.069767442,,0.8,2,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,E,79,F,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.11627907,,0.8,4,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,E,79,F,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.11627907,,0.8,5,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,E,79,F,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.11627907,,0.8,6,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,E,79,F,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.162790698,,0.8,8,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,E,79,F,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.302325581,,0.8,9,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,E,79,F,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.674418605,,0.8,13,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,E,79,F,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.162790698,,0.8,16,Days,FALSE,,,"Severe, requiring mechanical ventilation"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,F,55,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.255813954,,0.8,8,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,F,55,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.418604651,,0.8,14,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,F,55,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.302325581,,0.8,17,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,F,55,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,3.395348837,,0.8,20,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,F,55,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,3.395348837,,0.8,23,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,F,55,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,3.604651163,,0.8,30,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,G,56,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.186046512,,0.8,9,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,G,56,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.139534884,,0.8,11,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,G,56,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.88372093,,0.8,14,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,G,56,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2,,0.8,17,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,G,56,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.372093023,,0.8,21,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,G,56,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.88372093,,0.8,24,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,G,56,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,3.209302326,,0.8,28,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,G,56,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,3.395348837,,0.8,31,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,G,56,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,3.302325581,,0.8,35,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,H,71,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.255813954,,0.8,8,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,H,71,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.186046512,,0.8,10,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,H,71,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.418604651,,0.8,14,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,H,71,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.581395349,,0.8,17,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,H,71,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.093023256,,0.8,18,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,H,71,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.581395349,,0.8,21,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,H,71,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,3,,0.8,24,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,H,71,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,3.11627907,,0.8,28,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,H,71,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.88372093,,0.8,31,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,I,77,F,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.023255814,,0.8,15,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,I,77,F,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.093023256,,0.8,18,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,I,77,F,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.604651163,,0.8,21,Days,FALSE,,,"Severe, requiring supplemental oxygen therapy"
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,J,76,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.069767442,,0.8,4,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,J,76,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0,,0.8,5,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,J,76,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.046511628,,0.8,6,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,J,76,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.093023256,,0.8,7,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,J,76,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.209302326,,0.8,11,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,J,76,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,3.488372093,,0.8,14,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,J,76,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,3.093023256,,0.8,18,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,J,76,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,4.11627907,,0.8,21,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,J,76,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,4.209302326,,0.8,25,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,K,59,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.046511628,,0.8,13,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,K,59,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.976744186,,0.8,17,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,L,56,F,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0,,0.8,12,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,L,56,F,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.372093023,,0.8,16,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,L,56,F,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.976744186,,0.8,32,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,M,56,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.023255814,,0.8,4,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,M,56,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.046511628,,0.8,6,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,M,56,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0,,0.8,9,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,M,56,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.023255814,,0.8,13,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,M,56,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.023255814,,0.8,16,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,N,54,F,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.046511628,,0.8,4,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,N,54,F,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.046511628,,0.8,6,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,N,54,F,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.162790698,,0.8,11,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,N,54,F,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.186046512,,0.8,13,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,N,54,F,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.790697674,,0.8,16,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,N,54,F,South Korea,MERS-CoV,ELISA,IgG,OD ratio,3.093023256,,0.8,20,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,N,54,F,South Korea,MERS-CoV,ELISA,IgG,OD ratio,4.093023256,,0.8,27,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,P,35,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.023255814,,0.8,5,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,P,35,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.069767442,,0.8,7,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,P,35,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.023255814,,0.8,6,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,P,35,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.488372093,,0.8,9,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,Q,52,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.023255814,,0.8,4,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,Q,52,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.046511628,,0.8,5,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,Q,52,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.046511628,,0.8,8,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,Q,52,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,0.023255814,,0.8,10,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,Q,52,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,1.093023256,,0.8,14,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,Q,52,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.069767442,,0.8,17,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,Q,52,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,2.790697674,,0.8,21,Days,FALSE,,,Mild
26583829,Some of the points and curves in these figures are difficult to tell apart,Figure A,Q,52,M,South Korea,MERS-CoV,ELISA,IgG,OD ratio,3.860465116,,0.8,24,Days,FALSE,,,Mild